The	O
lack	O
of	O
NF-kappa	O
B	O
transactivation	O
and	O
PKC	O
epsilon	O
expression	O
in	O
CD4	B-cell_type
(	I-cell_type
+	I-cell_type
)	I-cell_type
CD8	I-cell_type
(	I-cell_type
+	I-cell_type
)	I-cell_type
thymocytes	I-cell_type
correlates	O
with	O
negative	O
selection	O
.	O

Deletion	O
of	O
autoreactive	B-cell_type
thymocytes	I-cell_type
at	O
the	O
DP	O
stage	O
is	O
the	O
basis	O
for	O
tolerance	O
to	O
thymus-expressed	B-protein
self	I-protein
antigens	I-protein
.	O

In	O
this	O
study	O
we	O
investigated	O
whether	O
distinct	O
signalling	O
pathways	O
are	O
induced	O
in	O
DP	B-cell_type
thymocytes	I-cell_type
as	O
compared	O
to	O
mature	B-cell_type
T	I-cell_type
cells	I-cell_type
upon	O
stimulation	O
with	O
antigen	O
.	O

Using	O
triple	O
transgenic	O
mice	O
expressing	O
a	O
TCR	B-DNA
transgene	I-DNA
,	O
dominant	B-protein
negative	I-protein
ras/Mek	I-protein
proteins	I-protein
and	O
a	O
reporter	B-DNA
gene	I-DNA
construct	I-DNA
with	O
AP-1	B-DNA
or	I-DNA
NF-kappa	I-DNA
B	I-DNA
binding	I-DNA
sites	I-DNA
,	O
we	O
showed	O
a	O
complete	O
lack	O
of	O
transcriptional	O
activity	O
of	O
NF-kappa	B-protein
B	I-protein
but	O
not	O
AP-1	B-protein
in	O
DP	B-cell_type
thymocytes	I-cell_type
,	O
whereas	O
both	O
were	O
transcriptionally	O
active	O
in	O
mature	B-cell_type
T	I-cell_type
cells	I-cell_type
after	O
antigenic	O
stimulation	O
.	O

Lack	O
of	O
NF-kappa	B-protein
B	I-protein
induction	O
correlated	O
with	O
increased	O
death	O
in	O
response	O
to	O
antigen	B-protein
.	O

AP-1	B-protein
induction	O
was	O
dependent	O
on	O
the	O
integrity	O
of	O
the	O
ras/Mek	O
pathway	O
indicating	O
that	O
this	O
pathway	O
was	O
activated	O
in	O
the	O
DP	B-cell_type
thymocytes	I-cell_type
.	O

In	O
contrast	O
,	O
we	O
found	O
a	O
complete	O
lack	O
of	O
constitutive	O
expression	O
of	O
the	O
epsilon	B-protein
isoform	I-protein
of	I-protein
Protein	I-protein
Kinase	I-protein
C	I-protein
(	O
PKC	B-protein
)	O
in	O
DP	B-cell_type
thymocytes	I-cell_type
,	O
although	O
it	O
was	O
present	O
in	O
mature	B-cell_type
thymocytes	I-cell_type
and	O
peripheral	B-cell_type
T	I-cell_type
cells	I-cell_type
.	O

Taken	O
together	O
the	O
results	O
suggest	O
that	O
the	O
lack	O
of	O
PKC	B-protein
epsilon	I-protein
in	O
DP	B-cell_type
thymocytes	I-cell_type
could	O
lead	O
to	O
the	O
absence	O
of	O
NF-kappa	B-protein
B	I-protein
activity	O
after	O
antigenic	O
stimulation	O
contributing	O
to	O
negative	O
selection	O
.	O

Cell	O
Death	O
and	O
Differentiation	O
(	O
2000	O
)	O
7	O
,	O
1253	O
-	O
1262	O
.	O

Cell	NULL
Death	NULL
and	NULL
Differentiation	NULL
(	NULL
2000	NULL
)	NULL
7	NULL
,	NULL
1253-1262	NULL
©	NULL
2000	NULL
Macmillan	NULL
Publishers	NULL
Ltd	NULL
All	NULL
rights	NULL
reserved	NULL
1350-9047/00	NULL
$	NULL
15.00	NULL
www.nature.com/edd	NULL
The	NULL
lack	NULL
of	NULL
NF-xB	NULL
transactivation	NULL
and	NULL
PKC	NULL
:	NULL
expression	NULL
in	NULL
CD4*CD8*	NULL
thymocytes	NULL
correlates	NULL
with	NULL
negative	NULL
selection	NULL
AK	NULL
Simon*	NULL
'	NULL
,	NULL
N	NULL
Auphan	NULL
'	NULL
,	NULL
M	NULL
Pophillat	NULL
'	NULL
,	NULL
C	NULL
Boyer	NULL
,	NULL
S	NULL
Ghosh	NULL
,	NULL
M	NULL
Rincon®	NULL
,	NULL
RA	NULL
Flavell	NULL
?	NULL

and	NULL
A-M	NULL
Schmitt-Verhulst	NULL
'	NULL
'	NULL
Centre	NULL
d'Immunologie	NULL
INSERM-CNRS	NULL
de	NULL
Marseille	NULL
Luminy	NULL
,	NULL
Marseille	NULL
,	NULL
France	NULL
2	NULL
Howard	NULL
Hughes	NULL
Medical	NULL
Institute	NULL
,	NULL
Yale	NULL
University	NULL
of	NULL
Medicine	NULL
,	NULL
New	NULL
Haven	NULL
,	NULL
CT	NULL
06510	NULL
,	NULL
USA	NULL
°	NULL
Department	NULL
of	NULL
Medicine	NULL
,	NULL
Program	NULL
of	NULL
Immunobiology	NULL
,	NULL
University	NULL
of	NULL
Vermont	NULL
,	NULL
Burlington	NULL
,	NULL
VT	NULL
05405	NULL
,	NULL
USA	NULL
*	NULL
Corresponding	NULL
author	NULL
:	NULL
AK	NULL
Simon	NULL
,	NULL
Immunology	NULL
Group	NULL
,	NULL
Institute	NULL
of	NULL
Molecular	NULL
Medicine	NULL
,	NULL
John	NULL
Radcliffe	NULL
Hospital	NULL
,	NULL
Headington	NULL
,	NULL
Oxford	NULL
OX3	NULL
9DS	NULL
,	NULL
UK	NULL
.	NULL

Tel	NULL
:	NULL
00	NULL
44	NULL
(	NULL
0	NULL
)	NULL
1865	NULL
222	NULL
403	NULL
;	NULL
Fax	NULL
:	NULL
00	NULL
44	NULL
(	NULL
0	NULL
)	NULL
1865	NULL
222	NULL
502	NULL
;	NULL
E-mail	NULL
:	NULL
katja.simon	NULL
@	NULL
ndm.ox.ac.uk	NULL
Received	NULL
25.2.00	NULL
;	NULL
revised	NULL
25.5.00	NULL
;	NULL
accepted	NULL
7.8.00	NULL
Edited	NULL
by	NULL
BA	NULL
Osborne	NULL
Abstract	NULL
Deletion	NULL
of	NULL
autoreactive	NULL
thymocytes	NULL
at	NULL
the	NULL
DP	NULL
stage	NULL
is	NULL
the	NULL
basis	NULL
for	NULL
tolerance	NULL
to	NULL
thymus-expressed	NULL
self	NULL
antigens	NULL
.	NULL

In	NULL
this	NULL
study	NULL
we	NULL
investigated	NULL
whether	NULL
distinct	NULL
signalling	NULL
pathways	NULL
are	NULL
induced	NULL
in	NULL
DP	NULL
thymocytes	NULL
as	NULL
compared	NULL
to	NULL
mature	NULL
T	NULL
cells	NULL
upon	NULL
stimulation	NULL
with	NULL
antigen	NULL
.	NULL

Using	NULL
triple	NULL
transgenic	NULL
mice	NULL
expressing	NULL
a	NULL
TCR	NULL
transgene	NULL
,	NULL
dominant	NULL
negative	NULL
ras/Mek	NULL
proteins	NULL
and	NULL
a	NULL
reporter	NULL
gene	NULL
construct	NULL
with	NULL
AP-1	NULL
or	NULL
NF-xB	NULL
binding	NULL
sites	NULL
,	NULL
we	NULL
showed	NULL
a	NULL
complete	NULL
lack	NULL
of	NULL
transcriptional	NULL
activity	NULL
of	NULL
NF-xB	NULL
but	NULL
not	NULL
AP-1	NULL
in	NULL
DP	NULL
thymocytes	NULL
,	NULL
whereas	NULL
both	NULL
were	NULL
transcriptionally	NULL
active	NULL
in	NULL
mature	NULL
T	NULL
cells	NULL
after	NULL
antigenic	NULL
stimulation	NULL
.	NULL

Lack	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
induction	NULL
correlated	NULL
with	NULL
increased	NULL
death	NULL
in	NULL
response	NULL
to	NULL
antigen	NULL
.	NULL

AP-1	NULL
induction	NULL
was	NULL
dependent	NULL
on	NULL
the	NULL
integrity	NULL
of	NULL
the	NULL
ras/Mek	NULL
pathway	NULL
indicating	NULL
that	NULL
this	NULL
pathway	NULL
was	NULL
activated	NULL
in	NULL
the	NULL
DP	NULL
thymocytes	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
we	NULL
found	NULL
a	NULL
complete	NULL
lack	NULL
of	NULL
constitutive	NULL
expression	NULL
of	NULL
the	NULL
:	NULL
isoform	NULL
of	NULL
Protein	NULL
Kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
in	NULL
DP	NULL
thymocytes	NULL
,	NULL
although	NULL
it	NULL
was	NULL
present	NULL
in	NULL
mature	NULL
thymocytes	NULL
and	NULL
peripheral	NULL
T	NULL
cells	NULL
.	NULL

Taken	NULL
together	NULL
the	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
lack	NULL
of	NULL
PKC	NULL
:	NULL
in	NULL
DP	NULL
thymocytes	NULL
could	NULL
lead	NULL
to	NULL
the	NULL
absence	NULL
of	NULL
NF-xB	NULL
activity	NULL
after	NULL
antigenic	NULL
stimulation	NULL
contributing	NULL
to	NULL
negative	NULL
selection	NULL
.	NULL

Cell	NULL
Death	NULL
and	NULL
Differentiation	NULL
(	NULL
2000	NULL
)	NULL
7	NULL
,	NULL
1253-1262	NULL
.	NULL

Keywords	NULL
:	NULL
CD4*CD8*	NULL
thymocytes	NULL
;	NULL
NF-	NULL
«	NULL
B	NULL
;	NULL
PKCs	NULL
;	NULL
ras/Mek	NULL
;	NULL
thymic	NULL
death	NULL
;	NULL
AP-1	NULL
Abbreviations	NULL
:	NULL
PKC	NULL
,	NULL
protein	NULL
kinase	NULL
C	NULL
;	NULL
TCR	NULL
,	NULL
T	NULL
cell	NULL
receptor	NULL
;	NULL
DP	NULL
,	NULL
double	NULL
positive	NULL
thymocytes	NULL
;	NULL
SP	NULL
,	NULL
single	NULL
positive	NULL
thymocytes	NULL
Introduction	NULL
Signals	NULL
mediated	NULL
by	NULL
engagement	NULL
of	NULL
the	NULL
TCR	NULL
initiate	NULL
the	NULL
positive	NULL
selection	NULL
of	NULL
CD4*CD8*	NULL
(	NULL
DP	NULL
)	NULL
thymocytes	NULL
into	NULL
mature	NULL
CD4*	NULL
or	NULL
CD8t	NULL
T	NULL
cells	NULL
.	NULL

This	NULL
process	NULL
involves	NULL
TCR-mediated	NULL
changes	NULL
in	NULL
gene	NULL
expression	NULL
that	NULL
lead	NULL
to	NULL
thymocyte	NULL
differentiation	NULL
and	NULL
survival	NULL
.	NULL

Negative	NULL
selection	NULL
of	NULL
autoreactive	NULL
thymocytes	NULL
also	NULL
requires	NULL
signalling	NULL
through	NULL
the	NULL
TCR	NULL
at	NULL
the	NULL
DP	NULL
stage	NULL
of	NULL
development	NULL
that	NULL
results	NULL
in	NULL
cell	NULL
death	NULL
.	NULL
``	NULL

Thus	NULL
signalling	NULL
is	NULL
pivotal	NULL
for	NULL
survival	NULL
or	NULL
death	NULL
.	NULL

It	NULL
remains	NULL
unclear	NULL
,	NULL
however	NULL
,	NULL
whether	NULL
the	NULL
signals	NULL
mediated	NULL
by	NULL
the	NULL
TCR	NULL
leading	NULL
to	NULL
positive	NULL
or	NULL
negative	NULL
selection	NULL
are	NULL
quantitatively	NULL
or	NULL
qualitatively	NULL
different	NULL
(	NULL
reviewed	NULL
in	NULL
*	NULL
)	NULL
.	NULL

The	NULL
molecular	NULL
basis	NULL
for	NULL
the	NULL
differential	NULL
response	NULL
to	NULL
antigen	NULL
between	NULL
DP	NULL
thymocytes	NULL
and	NULL
mature	NULL
T	NULL
cells	NULL
is	NULL
also	NULL
unknown	NULL
.	NULL

We	NULL
have	NULL
recently	NULL
shown	NULL
that	NULL
DP	NULL
thymocytes	NULL
have	NULL
a	NULL
nuclear	NULL
signalling	NULL
pattern	NULL
distinct	NULL
from	NULL
mature	NULL
T	NULL
cells	NULL
in	NULL
response	NULL
to	NULL
antigen.©	NULL
Antigenic	NULL
stimulation	NULL
leads	NULL
to	NULL
weak	NULL
NF-kB	NULL
DNA	NULL
binding	NULL
activity	NULL
but	NULL
strong	NULL
AP-1	NULL
activity	NULL
in	NULL
DP	NULL
thymocytes	NULL
as	NULL
compared	NULL
to	NULL
mature	NULL
T	NULL
cells	NULL
in	NULL
which	NULL
both	NULL
transcription	NULL
factors	NULL
are	NULL
It	NULL
is	NULL
not	NULL
clear	NULL
yet	NULL
how	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
is	NULL
induced	NULL
in	NULL
response	NULL
to	NULL
TCR	NULL
engagement	NULL
.	NULL

Signalling	NULL
for	NULL
activation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NF-kB	NULL
generally	NULL
involves	NULL
serine	NULL
phosphorylation	NULL
of	NULL
the	NULL
NF-xB	NULL
inhibitor	NULL
IxBa	NULL
«	NULL
followed	NULL
by	NULL
its	NULL
proteasomal	NULL
degradation	NULL
,	NULL
allowing	NULL
for	NULL
nuclear	NULL
translocation	NULL
of	NULL
NF-kB	NULL
.	NULL

Components	NULL
of	NULL
the	NULL
upstream	NULL
IxB	NULL
kinase	NULL
complex	NULL
,	NULL
in	NULL
particular	NULL
IKK	NULL
«	NULL
and	NULL
IKK	NULL
$	NULL
B	NULL
,	NULL
have	NULL
recently	NULL
been	NULL
identified	NULL
that	NULL
require	NULL
phosphorylation	NULL
on	NULL
specific	NULL
serine	NULL
residues	NULL
for	NULL
activation	NULL
(	NULL
reviewed	NULL
in	NULL
*	NULL
)	NULL
.	NULL

Upstream	NULL
of	NULL
the	NULL
IKKs	NULL
,	NULL
distinct	NULL
kinases	NULL
can	NULL
be	NULL
involved	NULL
depending	NULL
on	NULL
the	NULL
stimulus	NULL
or	NULL
on	NULL
the	NULL
cell	NULL
context	NULL
.	NULL

These	NULL
include	NULL
MAP3Ks	NULL
(	NULL
MEKK1	NULL
)	NULL
activated	NULL
via	NULL
the	NULL
ras	NULL
pathway	NULL
,	NULL
as	NULL
well	NULL
as	NULL
members	NULL
of	NULL
the	NULL
PKC	NULL
family	NULL
.	NULL
``	NULL

In	NULL
T	NULL
cell	NULL
lines	NULL
,	NULL
particular	NULL
PKC	NULL
isoforms	NULL
appear	NULL
to	NULL
be	NULL
efficient	NULL
at	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B.°	NULL
In	NULL
view	NULL
of	NULL
our	NULL
previous	NULL
observation	NULL
that	NULL
no	NULL
NF-kB	NULL
DNA	NULL
binding	NULL
was	NULL
detected	NULL
in	NULL
response	NULL
to	NULL
antigen	NULL
in	NULL
DP	NULL
thymocytes	NULL
and	NULL
of	NULL
the	NULL
accumulating	NULL
evidence	NULL
for	NULL
control	NULL
of	NULL
cell	NULL
survival	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
``	NULL
we	NULL
wanted	NULL
to	NULL
establish	NULL
and	NULL
analyse	NULL
further	NULL
the	NULL
basis	NULL
for	NULL
the	NULL
deficiency	NULL
in	NULL
NF-xB	NULL
induction	NULL
in	NULL
response	NULL
to	NULL
antigen	NULL
at	NULL
the	NULL
DP	NULL
thymocyte	NULL
stage	NULL
where	NULL
selection	NULL
events	NULL
occur	NULL
.	NULL

Some	NULL
components	NULL
of	NULL
the	NULL
ras	NULL
activation	NULL
pathway	NULL
appear	NULL
to	NULL
be	NULL
differentially	NULL
involved	NULL
in	NULL
thymic	NULL
positive	NULL
versus	NULL
negative	NULL
selection	NULL
(	NULL
reviewed	NULL
in	NULL
°	NULL
)	NULL
.	NULL

Disruption	NULL
of	NULL
the	NULL
Erk	NULL
pathway	NULL
that	NULL
is	NULL
controlled	NULL
by	NULL
ras	NULL
,	NULL
rafi	NULL
and	NULL
Mek-1/2	NULL
inhibits	NULL
positive	NULL
selection	NULL
and	NULL
leaves	NULL
negative	NULL
selection	NULL
intact	NULL
.	NULL

``	NULL
~	NULL
``	NULL
``	NULL
Inversely	NULL
,	NULL
there	NULL
is	NULL
some	NULL
evidence	NULL
that	NULL
the	NULL
JNK	NULL
and	NULL
p38	NULL
pathways	NULL
are	NULL
important	NULL
in	NULL
negative	NULL
selection	NULL
but	NULL
not	NULL
positive	NULL
selection	NULL
.	NULL
'	NULL

''	NULL
``	NULL
``	NULL
Another	NULL
arm	NULL
of	NULL
TCR	NULL
signalling	NULL
,	NULL
i.e	NULL
.	NULL

the	NULL
activation	NULL
of	NULL
the	NULL
phospholipase	NULL
C	NULL
,	NULL
subsequent	NULL
calcium	NULL
influx	NULL
and	NULL
activation	NULL
of	NULL
PKCs	NULL
has	NULL
been	NULL
less	NULL
extensively	NULL
studied	NULL
in	NULL
developing	NULL
thymocytes	NULL
.	NULL

When	NULL
the	NULL
calcium/	NULL
calcineurin-dependent	NULL
pathway	NULL
is	NULL
inhibited	NULL
,	NULL
deletion	NULL
of	NULL
autoreactive	NULL
thymocytes	NULL
can	NULL
occur	NULL
provided	NULL
there	NULL
is	NULL
a	NULL
strong	NULL
stimulus	NULL
,	NULL
'-	NULL
'	NULL
``	NULL
whereas	NULL
positive	NULL
selection	NULL
is	NULL
blocked	NULL
.	NULL
``	NULL

''	NULL
Surprisingly	NULL
there	NULL
are	NULL
very	NULL
few	NULL
reports	NULL
on	NULL
the	NULL
role	NULL
of	NULL
PKCs	NULL
in	NULL
thymic	NULL
selection	NULL
events	NULL
.	NULL

Considering	NULL
that	NULL
Lack	NULL
of	NULL
NF-xB	NULL
and	NULL
PKC	NULL
:	NULL
in	NULL
CD4*CD8*	NULL
thymocytes	NULL
AK	NULL
Simon	NULL
et	NULL
al	NULL
1254	NULL
upstream	NULL
signalling	NULL
molecules	NULL
not	NULL
only	NULL
control	NULL
the	NULL
binding	NULL
of	NULL
transcription	NULL
factors	NULL
to	NULL
the	NULL
DNA	NULL
but	NULL
also	NULL
regulate	NULL
nuclear	NULL
translocation	NULL
and	NULL
posttranslational	NULL
modification	NULL
of	NULL
preformed	NULL
complexes	NULL
required	NULL
to	NULL
mediate	NULL
transcriptional	NULL
activity	NULL
,	NULL
we	NULL
first	NULL
asked	NULL
whether	NULL
previously	NULL
detected	NULL
DNA-binding	NULL
activity	NULL
reflects	NULL
transactivation	NULL
.	NULL

Second	NULL
,	NULL
we	NULL
evaluated	NULL
the	NULL
role	NULL
of	NULL
the	NULL
ras/Mek	NULL
pathway	NULL
in	NULL
DNA	NULL
binding	NULL
activity	NULL
as	NULL
well	NULL
as	NULL
transactivation	NULL
of	NULL
AP-1	NULL
and	NULL
NF-kB	NULL
.	NULL

Third	NULL
,	NULL
we	NULL
investigated	NULL
whether	NULL
developmental	NULL
control	NULL
of	NULL
expression	NULL
of	NULL
distinct	NULL
PKC	NULL
isoforms	NULL
could	NULL
be	NULL
associated	NULL
with	NULL
defective	NULL
antigen-induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
DP	NULL
thymocytes	NULL
.	NULL

Using	NULL
triple	NULL
transgenic	NULL
mice	NULL
expressing	NULL
(	NULL
i	NULL
)	NULL
a	NULL
TCR	NULL
transgene	NULL
,	NULL
(	NULL
ii	NULL
)	NULL
the	NULL
luciferase	NULL
reporter	NULL
transgene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
AP-1	NULL
and	NULL
NF-xB	NULL
DNA	NULL
binding	NULL
sites	NULL
and	NULL
(	NULL
iii	NULL
)	NULL
transdominant	NULL
negative	NULL
Mek	NULL
and	NULL
ras	NULL
proteins	NULL
(	NULL
dnras/dMek	NULL
)	NULL
in	NULL
the	NULL
T	NULL
cell	NULL
lineage	NULL
,	NULL
we	NULL
show	NULL
a	NULL
lack	NULL
of	NULL
NF-xB	NULL
transactivation	NULL
in	NULL
response	NULL
to	NULL
antigen	NULL
,	NULL
confirming	NULL
our	NULL
previous	NULL
results	NULL
on	NULL
DNA	NULL
binding	NULL
.	NULL

We	NULL
observed	NULL
that	NULL
during	NULL
the	NULL
development	NULL
of	NULL
DP	NULL
to	NULL
thymic	NULL
SP	NULL
CD8	NULL
and	NULL
then	NULL
mature	NULL
CD8	NULL
T	NULL
cells	NULL
NF-kB	NULL
became	NULL
increasingly	NULL
transcriptionally	NULL
active	NULL
,	NULL
whereas	NULL
the	NULL
susceptibility	NULL
to	NULL
death	NULL
in	NULL
response	NULL
to	NULL
antigen	NULL
decreased	NULL
.	NULL

Additionally	NULL
AP-1	NULL
,	NULL
which	NULL
is	NULL
transcriptionally	NULL
active	NULL
in	NULL
response	NULL
to	NULL
antigen	NULL
in	NULL
DP	NULL
thymocytes	NULL
,	NULL
was	NULL
partly	NULL
inhibited	NULL
by	NULL
the	NULL
expression	NULL
of	NULL
the	NULL
dnras/dMek	NULL
proteins	NULL
,	NULL
indicating	NULL
that	NULL
the	NULL
lack	NULL
of	NULL
NF-kB	NULL
is	NULL
not	NULL
due	NULL
to	NULL
a	NULL
defect	NULL
in	NULL
ras/Mek	NULL
pathway	NULL
.	NULL

However	NULL
,	NULL
after	NULL
phorbol	NULL
ester/	NULL
ionophore	NULL
stimulation	NULL
NF-kB	NULL
was	NULL
transcriptionally	NULL
active	NULL
and	NULL
this	NULL
activity	NULL
was	NULL
also	NULL
partly	NULL
affected	NULL
by	NULL
the	NULL
inhibition	NULL
of	NULL
the	NULL
ras	NULL
pathway	NULL
.	NULL

Moreover	NULL
we	NULL
showed	NULL
a	NULL
deficiency	NULL
of	NULL
PKCs	NULL
protein	NULL
in	NULL
DP	NULL
thymocytes	NULL
whereas	NULL
PKCa	NULL
and	NULL
B	NULL
are	NULL
well-expressed	NULL
,	NULL
and	NULL
PKCs	NULL
was	NULL
present	NULL
in	NULL
thymic	NULL
SP	NULL
and	NULL
peripheral	NULL
T	NULL
cells	NULL
.	NULL

These	NULL
findings	NULL
suggest	NULL
that	NULL
lack	NULL
of	NULL
PKCz	NULL
in	NULL
DP	NULL
thymocytes	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
absence	NULL
of	NULL
transactivation	NULL
and	NULL
increased	NULL
sensitivity	NULL
to	NULL
apoptosis	NULL
at	NULL
this	NULL
developmental	NULL
stage	NULL
.	NULL

Results	NULL
Inverse	NULL
correlation	NULL
of	NULL
death	NULL
and	NULL
NF-xB	NULL
transcriptional	NULL
activity	NULL
in	NULL
CD4*CD8*	NULL
thymocytes	NULL
induced	NULL
by	NULL
antigen	NULL
We	NULL
have	NULL
previously	NULL
demonstrated	NULL
that	NULL
antigen	NULL
fails	NULL
to	NULL
induce	NULL
NF-kB	NULL
DNA-binding	NULL
activity	NULL
in	NULL
response	NULL
to	NULL
antigen	NULL
in	NULL
DP	NULL
thymocytes	NULL
whereas	NULL
AP-1	NULL
binding	NULL
activity	NULL
is	NULL
induced	NULL
at	NULL
this	NULL
stage	NULL
of	NULL
development	NULL
.	NULL

It	NULL
remained	NULL
to	NULL
be	NULL
shown	NULL
,	NULL
however	NULL
,	NULL
whether	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
transcription	NULL
factors	NULL
demonstrated	NULL
in	NULL
cell	NULL
extracts	NULL
correlated	NULL
with	NULL
transcriptional	NULL
activation	NULL
.	NULL

For	NULL
that	NULL
purpose	NULL
,	NULL
the	NULL
TCR	NULL
transgenic	NULL
mice	NULL
were	NULL
crossed	NULL
onto	NULL
AP-1	NULL
or	NULL
NF-xB	NULL
luciferase	NULL
reporter	NULL
mice	NULL
.	NULL

To	NULL
determine	NULL
transcriptional	NULL
activity	NULL
of	NULL
NF-xB	NULL
and	NULL
AP-1	NULL
,	NULL
total	NULL
thymocytes	NULL
,	NULL
preselection	NULL
DP	NULL
(	NULL
MHC	NULL
class	NULL
1'°	NULL
``	NULL
TCR	NULL
``	NULL
CD69	NULL
``	NULL
)	NULL
thymocytes	NULL
,	NULL
thymic	NULL
CD8*	NULL
or	NULL
peripheral	NULL
CD8*	NULL
T	NULL
cells	NULL
from	NULL
TCR	NULL
transgenic	NULL
mice	NULL
were	NULL
stimulated	NULL
in	NULL
vitro	NULL
with	NULL
either	NULL
the	NULL
nominal	NULL
antigen	NULL
H-2K	NULL
``	NULL
(	NULL
with	NULL
endogenous	NULL
level	NULL
or	NULL
with	NULL
additional	NULL
cognate	NULL
peptide	NULL
-see	NULL
Materials	NULL
and	NULL
Methods	NULL
)	NULL
or	NULL
control	NULL
H-2	NULL
``	NULL
expressing	NULL
cells	NULL
.	NULL

Then	NULL
luciferase	NULL
activity	NULL
was	NULL
determined	NULL
as	NULL
a	NULL
measure	NULL
of	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
the	NULL
respective	NULL
factors	NULL
.	NULL

The	NULL
degree	NULL
of	NULL
stimulation	NULL
was	NULL
measured	NULL
by	NULL
detection	NULL
of	NULL
CD69	NULL
(	NULL
not	NULL
shown	NULL
)	NULL
and	NULL
Annexin	NULL
V	NULL
staining	NULL
was	NULL
Cell	NULL
Death	NULL
and	NULL
Differentiation	NULL
an	NULL
indication	NULL
for	NULL
dying	NULL
cells	NULL
undergoing	NULL
negative	NULL
selection	NULL
(	NULL
Figure	NULL
1C	NULL
)	NULL
.	NULL

Positive	NULL
controls	NULL
included	NULL
stimulation	NULL
of	NULL
peripheral	NULL
T	NULL
cells	NULL
with	NULL
H-2K®	NULL
expressing	NULL
APCs	NULL
.	NULL

After	NULL
6	NULL
and	NULL
12	NULL
h	NULL
stimulation	NULL
peripheral	NULL
T	NULL
cells	NULL
remained	NULL
negative	NULL
for	NULL
AP-1	NULL
and	NULL
NF-xB	NULL
transcriptional	NULL
activity	NULL
whereas	NULL
after	NULL
24	NULL
h	NULL
stimulation	NULL
860	NULL
RLU	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
90	NULL
RLU	NULL
for	NULL
AP-1	NULL
luciferase	NULL
activity	NULL
were	NULL
measured	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Immature	NULL
thymocytes	NULL
are	NULL
expected	NULL
to	NULL
yield	NULL
lower	NULL
activities	NULL
than	NULL
mature	NULL
T	NULL
cells	NULL
as	NULL
they	NULL
express	NULL
lower	NULL
levels	NULL
of	NULL
TCR	NULL
.	NULL

The	NULL
phenotype	NULL
of	NULL
thymocytes	NULL
was	NULL
determined	NULL
by	NULL
staining	NULL
with	NULL
anti-CD4	NULL
and	NULL
anti-CD8	NULL
antibodies	NULL
(	NULL
Figure	NULL
1D	NULL
)	NULL
.	NULL

Note	NULL
that	NULL
the	NULL
lower	NULL
left	NULL
quadrant	NULL
contains	NULL
mainly	NULL
irradiated	NULL
APCs	NULL
depleted	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

As	NULL
expected	NULL
after	NULL
addition	NULL
of	NULL
antigen	NULL
the	NULL
number	NULL
of	NULL
DP	NULL
cells	NULL
was	NULL
reduced	NULL
and	NULL
CD4	NULL
and	NULL
CD8	NULL
expression	NULL
was	NULL
downmodulated	NULL
.	NULL

After	NULL
53	NULL
h	NULL
of	NULL
culture	NULL
nearly	NULL
all	NULL
DP	NULL
thymocytes	NULL
have	NULL
died	NULL
(	NULL
Figure	NULL
1D	NULL
)	NULL
,	NULL
not	NULL
surprisingly	NULL
neither	NULL
AP-1	NULL
nor	NULL
NF-kB	NULL
were	NULL
detected	NULL
(	NULL
Figure	NULL
1A	NULL
,	NULL
B	NULL
)	NULL
.	NULL

Consistent	NULL
with	NULL
our	NULL
previous	NULL
results	NULL
using	NULL
gel	NULL
shift	NULL
assays	NULL
,	NULL
``	NULL
AP-1	NULL
was	NULL
transcriptionally	NULL
active	NULL
in	NULL
DP	NULL
thymocytes	NULL
when	NULL
these	NULL
were	NULL
stimulated	NULL
for	NULL
39	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
antigen	NULL
and	NULL
specific	NULL
peptide	NULL
(	NULL
Figure	NULL
1B	NULL
)	NULL
.	NULL

However	NULL
,	NULL
at	NULL
any	NULL
time	NULL
point	NULL
after	NULL
antigen	NULL
stimulation	NULL
and	NULL
even	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
peptide	NULL
,	NULL
NF-kB	NULL
was	NULL
not	NULL
transcriptionally	NULL
active	NULL
in	NULL
the	NULL
DP	NULL
thymocytes	NULL
(	NULL
Figure	NULL
1A	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
total	NULL
thymocytes	NULL
showed	NULL
NF-kB	NULL
activity	NULL
after	NULL
39	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
H-2K	NULL
``	NULL
®	NULL
and	NULL
addition	NULL
of	NULL
exogenous	NULL
peptide	NULL
or	NULL
53	NULL
h	NULL
without	NULL
additional	NULL
peptide	NULL
.	NULL

This	NULL
activity	NULL
is	NULL
due	NULL
to	NULL
thymic	NULL
SP	NULL
present	NULL
in	NULL
the	NULL
total	NULL
population	NULL
(	NULL
Figure	NULL
1C	NULL
)	NULL
since	NULL
DP	NULL
have	NULL
disappeared	NULL
at	NULL
that	NULL
time	NULL
point	NULL
(	NULL
Figure	NULL
1D	NULL
)	NULL
.	NULL

Thus	NULL
not	NULL
only	NULL
is	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
NF-xB	NULL
reduced	NULL
in	NULL
DP	NULL
thymocytes	NULL
but	NULL
its	NULL
capacity	NULL
to	NULL
induce	NULL
gene	NULL
transcription	NULL
in	NULL
response	NULL
to	NULL
antigen	NULL
is	NULL
completely	NULL
abolished	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
lack	NULL
of	NULL
NF-xB	NULL
activation	NULL
at	NULL
the	NULL
DP	NULL
stage	NULL
of	NULL
development	NULL
correlated	NULL
with	NULL
the	NULL
capacity	NULL
of	NULL
antigen	NULL
to	NULL
induce	NULL
death	NULL
.	NULL

Twenty	NULL
per	NULL
cent	NULL
of	NULL
DP	NULL
died	NULL
in	NULL
response	NULL
to	NULL
antigen	NULL
(	NULL
background	NULL
of	NULL
death	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
syngeneic	NULL
APCs	NULL
was	NULL
subtracted	NULL
)	NULL
according	NULL
to	NULL
Annexin	NULL
V	NULL
staining	NULL
(	NULL
Figure	NULL
1C	NULL
)	NULL
.	NULL

Only	NULL
10	NULL
%	NULL
of	NULL
thymic	NULL
SP	NULL
and	NULL
less	NULL
than	NULL
5	NULL
%	NULL
of	NULL
peripheral	NULL
CD8*	NULL
died	NULL
in	NULL
response	NULL
to	NULL
antigen	NULL
(	NULL
Note	NULL
:	NULL
in	NULL
this	NULL
experiment	NULL
DP	NULL
and	NULL
peripheral	NULL
SP	NULL
were	NULL
96	NULL
%	NULL
pure	NULL
whereas	NULL
thymic	NULL
SP	NULL
were	NULL
enriched	NULL
to	NULL
70	NULL
%	NULL
,	NULL
the	NULL
remaining	NULL
30	NULL
%	NULL
being	NULL
mainly	NULL
DP	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
NF-kB	NULL
transcriptional	NULL
activity	NULL
is	NULL
undetectable	NULL
in	NULL
DP	NULL
thymocytes	NULL
whereas	NULL
some	NULL
is	NULL
detected	NULL
in	NULL
thymic	NULL
SP	NULL
,	NULL
and	NULL
in	NULL
the	NULL
mature	NULL
peripheral	NULL
T	NULL
cell	NULL
population	NULL
NF-xB	NULL
is	NULL
increased	NULL
threefold	NULL
as	NULL
compared	NULL
to	NULL
thymic	NULL
SP	NULL
(	NULL
Figure	NULL
1C	NULL
)	NULL
.	NULL

Hence	NULL
,	NULL
there	NULL
is	NULL
an	NULL
inverse	NULL
relationship	NULL
between	NULL
susceptibility	NULL
to	NULL
death	NULL
and	NULL
transcriptional	NULL
activity	NULL
of	NULL
NF-xB	NULL
in	NULL
response	NULL
to	NULL
antigen	NULL
during	NULL
the	NULL
development	NULL
of	NULL
thymocytes	NULL
.	NULL

The	NULL
relative	NULL
luciferase	NULL
units	NULL
(	NULL
RLU	NULL
)	NULL
varied	NULL
between	NULL
experiments	NULL
(	NULL
see	NULL
Figure	NULL
1A	NULL
,	NULL
C	NULL
)	NULL
,	NULL
but	NULL
relative	NULL
results	NULL
obtained	NULL
were	NULL
reproducible	NULL
.	NULL

The	NULL
ras/Mek	NULL
pathway	NULL
is	NULL
functional	NULL
in	NULL
DP	NULL
thymocytes	NULL
and	NULL
controls	NULL
AP-1	NULL
binding	NULL
activity	NULL
in	NULL
response	NULL
to	NULL
antigen	NULL
To	NULL
gain	NULL
insight	NULL
into	NULL
the	NULL
role	NULL
of	NULL
the	NULL
ras/Mek	NULL
pathway	NULL
after	NULL
antigenic	NULL
stimulation	NULL
we	NULL
crossed	NULL
mice	NULL
expressing	NULL
both	NULL
the	NULL
dominant	NULL
negative	NULL
proteins	NULL
of	NULL
ras	NULL
and	NULL
Mek-1	NULL
(	NULL
dnras/dMek	NULL
)	NULL
,	NULL
showing	NULL
a	NULL
complete	NULL
inhibition	NULL
of	NULL
ras	NULL
signalling	NULL
,	NULL
°	NULL
onto	NULL
the	NULL
Lack	NULL
of	NULL
NF-kB	NULL
and	NULL
PKC	NULL
:	NULL
in	NULL
CD4*CD8*	NULL
thymocytes	NULL
1255	NULL
AK	NULL
Simon	NULL
et	NULL
al	NULL
A	NULL
80	NULL
c	NULL
1000	NULL
NF-KB	NULL
lue	NULL
NF-kB	NULL
luc	NULL
60	NULL
-	NULL
750	NULL
p	NULL
404	NULL
=	NULL
3	NULL
a	NULL
500	NULL
20+	NULL
250	NULL
``	NULL
0	NULL
C	NULL
18h	NULL
B	NULL
25	NULL
C	NULL
39h	NULL
0	NULL
&	NULL
m	NULL
53n	NULL
C	NULL
205	NULL
%	NULL
death	NULL
20	NULL
{	NULL
s	NULL
3	NULL
15	NULL
|	NULL
5	NULL
154	NULL
4	NULL
``	NULL
10	NULL
+	NULL
§	NULL
107	NULL
4	NULL
«	NULL
5	NULL
{	NULL
»	NULL
0	NULL
5	NULL
0	NULL
4	NULL
0	NULL
Sp	NULL
SpLN	NULL
Ttot	NULL
Ttot	NULL
DP	NULL
DP	NULL
+peptide	NULL
+peptide	NULL
+	NULL
H2K	NULL
+	NULL
peptide	NULL
+H-2Kb	NULL
P	NULL
DP	NULL
thymocytes	NULL
APC	NULL
CD8	NULL
Oh	NULL
24	NULL
18h	NULL
T	NULL
TP	NULL
m	NULL
7	NULL
39h	NULL
ats	NULL
5	NULL
is	NULL
53h	NULL
T	NULL
T	NULL
m.	NULL
102	NULL
#	NULL
ao	NULL
``	NULL
_	NULL
40°	NULL
adel	NULL
aot	NULL
ot	NULL
ao	NULL
``	NULL
H-2K	NULL
«	NULL
H-2K®	NULL
H-2K	NULL
``	NULL
+	NULL
peptide	NULL
Figure	NULL
1	NULL
-	NULL
DP	NULL
thymocytes	NULL
lack	NULL
NF-xB	NULL
transactivation	NULL
in	NULL
response	NULL
to	NULL
antigen	NULL
.	NULL

2	NULL
x	NULL
10°	NULL
total	NULL
thymocytes	NULL
(	NULL
Ttot	NULL
)	NULL
,	NULL
purified	NULL
DP	NULL
thymocytes	NULL
(	NULL
DP	NULL
)	NULL
,	NULL
thymic	NULL
CD8+*	NULL
(	NULL
SP	NULL
)	NULL
or	NULL
peripheral	NULL
CD8*	NULL
(	NULL
SP	NULL
``	NULL
)	NULL
from	NULL
double	NULL
transgenic	NULL
TCR	NULL
x	NULL
NF-xB	NULL
luciferase	NULL
(	NULL
A	NULL
)	NULL
or	NULL
TCR	NULL
x	NULL
AP-1	NULL
luciferase	NULL
(	NULL
B	NULL
)	NULL
mice	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
H-2	NULL
``	NULL
or	NULL
H-2	NULL
``	NULL
APC	NULL
for	NULL
18	NULL
,	NULL
39	NULL
or	NULL
53h	NULL
.	NULL

Where	NULL
indicated	NULL
107	NULL
``	NULL
M	NULL
specific	NULL
antigenic	NULL
peptide	NULL
was	NULL
added	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
measured	NULL
in	NULL
the	NULL
cell	NULL
extracts	NULL
and	NULL
values	NULL
for	NULL
non-stimulated	NULL
samples	NULL
(	NULL
H-2	NULL
APC	NULL
)	NULL
were	NULL
subtracted	NULL
.	NULL

The	NULL
experiments	NULL
shown	NULL
for	NULL
NF-xB	NULL
and	NULL
AP-1	NULL
are	NULL
representative	NULL
experiments	NULL
out	NULL
of	NULL
three	NULL
.	NULL

In	NULL
(	NULL
C	NULL
)	NULL
luciferase	NULL
activity	NULL
for	NULL
NF-xB	NULL
and	NULL
percentage	NULL
of	NULL
Annexin	NULL
V	NULL
positive	NULL
cells	NULL
were	NULL
measured	NULL
after	NULL
stimulation	NULL
with	NULL
H-2	NULL
``	NULL
and	NULL
peptide	NULL
for	NULL
39	NULL
h	NULL
in	NULL
the	NULL
same	NULL
experiment	NULL
.	NULL

Triplicates	NULL
were	NULL
used	NULL
to	NULL
calculate	NULL
the	NULL
standard	NULL
deviation	NULL
based	NULL
on	NULL
small	NULL
sample	NULL
size	NULL
.	NULL

(	NULL
D	NULL
)	NULL
shows	NULL
the	NULL
staining	NULL
with	NULL
anti-	NULL
CD4	NULL
and	NULL
anti-CD8	NULL
antibodies	NULL
of	NULL
APC	NULL
and	NULL
purified	NULL
DP	NULL
thymocytes	NULL
before	NULL
stimulation	NULL
(	NULL
two	NULL
upper	NULL
dot	NULL
blots	NULL
)	NULL
and	NULL
purified	NULL
DP	NULL
thymocytes	NULL
at	NULL
18	NULL
,	NULL
39	NULL
and	NULL
53h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
APC	NULL
with	NULL
H-2K	NULL
``	NULL
,	NULL
H-2K®	NULL
or	NULL
H-2K®+peptide	NULL
where	NULL
indicated	NULL
(	NULL
nine	NULL
lower	NULL
dot	NULL
blots	NULL
)	NULL
.	NULL

Note	NULL
that	NULL
in	NULL
the	NULL
dot	NULL
blots	NULL
where	NULL
APCs	NULL
have	NULL
been	NULL
added	NULL
,	NULL
lower	NULL
left	NULL
quadrants	NULL
contain	NULL
APCs	NULL
depleted	NULL
of	NULL
T	NULL
cells	NULL
Cell	NULL
Death	NULL
and	NULL
Differentiation	NULL
Lack	NULL
of	NULL
NF-xB	NULL
and	NULL
PKC	NULL
:	NULL
in	NULL
CD4*CD8*	NULL
thymocytes	NULL
AK	NULL
Simon	NULL
et	NULL
al	NULL
1256	NULL
TCR	NULL
transgenic	NULL
mice	NULL
KB5.C20	NULL
recognizing	NULL
the	NULL
alloantigen	NULL
H-2K°	NULL
.	NULL

In	NULL
the	NULL
H-2	NULL
``	NULL
°	NULL
negative	NULL
selection	NULL
background	NULL
,	NULL
thymocytes	NULL
from	NULL
TCR	NULL
transgenic	NULL
mice	NULL
showed	NULL
the	NULL
same	NULL
phenotype	NULL
whether	NULL
or	NULL
not	NULL
they	NULL
additionally	NULL
expressed	NULL
dnras/dMek	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
confirming	NULL
results	NULL
obtained	NULL
in	NULL
other	NULL
TCR	NULL
transgenic	NULL
systems	NULL
.	NULL
``	NULL

On	NULL
the	NULL
H-2*	NULL
positive	NULL
selection	NULL
background	NULL
mice	NULL
expressing	NULL
dnras/dMek	NULL
had	NULL
fewer	NULL
single	NULL
positive	NULL
(	NULL
SP	NULL
)	NULL
CD8	NULL
cells	NULL
(	NULL
reduced	NULL
2.6-fold+0.6	NULL
)	NULL
.	NULL

This	NULL
phenotype	NULL
was	NULL
less	NULL
drastic	NULL
than	NULL
the	NULL
one	NULL
described	NULL
in	NULL
other	NULL
TCR	NULL
transgenic	NULL
systems	NULL
with	NULL
inhibition	NULL
of	NULL
ras	NULL
signalling	NULL
.	NULL

*	NULL
``	NULL
Furthermore	NULL
the	NULL
mature	NULL
SP	NULL
CD8*	NULL
expressed	NULL
the	NULL
same	NULL
level	NULL
of	NULL
transgenic	NULL
TCR	NULL
whether	NULL
or	NULL
not	NULL
they	NULL
expressed	NULL
dnras/dMek	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

However	NULL
,	NULL
thymocytes	NULL
from	NULL
dnras/dMek	NULL
mice	NULL
proliferated	NULL
less	NULL
well	NULL
to	NULL
PMA¥/ionomycin	NULL
(	NULL
64	NULL
%	NULL
reduction	NULL
)	NULL
,	NULL
anti	NULL
CD3/PMA	NULL
(	NULL
61	NULL
%	NULL
reduction	NULL
)	NULL
or	NULL
antigen	NULL
(	NULL
73	NULL
%	NULL
reduction	NULL
)	NULL
indicating	NULL
that	NULL
the	NULL
transdominant	NULL
proteins	NULL
are	NULL
functional	NULL
in	NULL
thymocytes	NULL
.	NULL

In	NULL
contrast	NULL
we	NULL
detected	NULL
no	NULL
difference	NULL
in	NULL
proliferation	NULL
capacities	NULL
to	NULL
the	NULL
same	NULL
stimuli	NULL
in	NULL
the	NULL
periphery	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

This	NULL
is	NULL
consistent	NULL
with	NULL
the	NULL
low	NULL
transgene	NULL
expression	NULL
generally	NULL
observed	NULL
in	NULL
peripheral	NULL
T	NULL
cells	NULL
under	NULL
the	NULL
control	NULL
of	NULL
the	NULL
Ick	NULL
proximal	NULL
promoter	NULL
.	NULL
``	NULL

After	NULL
stimulation	NULL
with	NULL
antigen	NULL
without	NULL
or	NULL
with	NULL
additional	NULL
cognate	NULL
peptide	NULL
for	NULL
18	NULL
h	NULL
,	NULL
cell	NULL
extracts	NULL
were	NULL
analysed	NULL
in	NULL
gel	NULL
shift	NULL
assays	NULL
.	NULL

Controls	NULL
using	NULL
Oct-1	NULL
oligonucleotides	NULL
were	NULL
performed	NULL
.	NULL

Oct-1	NULL
transcriptional	NULL
activity	NULL
was	NULL
detected	NULL
in	NULL
all	NULL
lanes	NULL
,	NULL
although	NULL
cell	NULL
extracts	NULL
from	NULL
dnras/dMek	NULL
mice	NULL
showed	NULL
slightly	NULL
weaker	NULL
activities	NULL
than	NULL
extracts	NULL
from	NULL
littermates	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

As	NULL
previously	NULL
described	NULL
,	NULL
antigen	NULL
induced	NULL
AP-1	NULL
DNA	NULL
binding	NULL
which	NULL
was	NULL
further	NULL
increased	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
additional	NULL
cognate	NULL
peptide	NULL
.	NULL

Expression	NULL
of	NULL
dnras/dMek	NULL
reduced	NULL
AP-1	NULL
DNA	NULL
binding	NULL
activity	NULL
threefold	NULL
(	NULL
Figure	NULL
2	NULL
,	NULL
upper	NULL
panel	NULL
)	NULL
.	NULL

NF-xB	NULL
DNA	NULL
binding	NULL
was	NULL
only	NULL
weakly	NULL
induced	NULL
at	NULL
the	NULL
DP	NULL
stage	NULL
of	NULL
development	NULL
even	NULL
after	NULL
stimulation	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
additional	NULL
cognate	NULL
peptide	NULL
.	NULL

This	NULL
weak	NULL
induction	NULL
was	NULL
further	NULL
reduced	NULL
in	NULL
thymocytes	NULL
from	NULL
dnras/	NULL
dMek	NULL
mice	NULL
(	NULL
Figure	NULL
2	NULL
,	NULL
lower	NULL
panel	NULL
)	NULL
.	NULL

These	NULL
results	NULL
demonstrate	NULL
that	NULL
the	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
AP-1	NULL
after	NULL
stimulation	NULL
with	NULL
antigen	NULL
is	NULL
partially	NULL
dependent	NULL
on	NULL
the	NULL
ras/	NULL
Mek	NULL
pathway	NULL
.	NULL

For	NULL
NF-	NULL
«	NULL
B	NULL
the	NULL
signal	NULL
in	NULL
DP	NULL
thymocytes	NULL
was	NULL
too	NULL
weak	NULL
to	NULL
affirm	NULL
it	NULL
with	NULL
certainty	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
control	NULL
over	NULL
transcriptional	NULL
activity	NULL
by	NULL
the	NULL
ras/Mek	NULL
pathway	NULL
further	NULL
,	NULL
triple	NULL
transgenic	NULL
mice	NULL
expressing	NULL
the	NULL
TCR	NULL
transgene	NULL
,	NULL
the	NULL
luciferase	NULL
reporter	NULL
transgene	NULL
under	NULL
the	NULL
control	NULL
of	NULL
AP-1	NULL
binding	NULL
sites	NULL
and	NULL
transdominant	NULL
negative	NULL
Mek	NULL
and	NULL
ras	NULL
proteins	NULL
were	NULL
made	NULL
.	NULL

DP	NULL
thymocytes	NULL
from	NULL
littermate	NULL
mice	NULL
expressing	NULL
only	NULL
AP-1	NULL
luciferase	NULL
and	NULL
the	NULL
TCR	NULL
transgene	NULL
show	NULL
an	NULL
increased	NULL
transcriptional	NULL
activity	NULL
for	NULL
AP-1	NULL
after	NULL
39	NULL
h	NULL
(	NULL
Figure	NULL
3A	NULL
)	NULL
in	NULL
response	NULL
to	NULL
antigen	NULL
and	NULL
cognate	NULL
peptide	NULL
.	NULL

This	NULL
is	NULL
consistent	NULL
with	NULL
our	NULL
gel	NULL
shift	NULL
results	NULL
.	NULL

However	NULL
,	NULL
expression	NULL
of	NULL
the	NULL
dnras/dMek	NULL
transgene	NULL
reduces	NULL
this	NULL
signal	NULL
twofold	NULL
(	NULL
Figure	NULL
3A	NULL
)	NULL
.	NULL

Considering	NULL
the	NULL
total	NULL
absence	NULL
of	NULL
NF-xB	NULL
activity	NULL
in	NULL
response	NULL
to	NULL
antigen	NULL
in	NULL
DP	NULL
cells	NULL
,	NULL
it	NULL
is	NULL
difficult	NULL
to	NULL
determine	NULL
the	NULL
role	NULL
of	NULL
the	NULL
ras/Mek	NULL
pathway	NULL
for	NULL
this	NULL
factor	NULL
using	NULL
the	NULL
luciferase	NULL
read-out	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
absence	NULL
of	NULL
NF-kB	NULL
transactivation	NULL
in	NULL
total	NULL
thymocytes	NULL
from	NULL
dnras/dMek	NULL
mice	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
could	NULL
either	NULL
be	NULL
due	NULL
to	NULL
the	NULL
absence	NULL
of	NULL
SP	NULL
thymocytes	NULL
in	NULL
these	NULL
mice	NULL
or	NULL
to	NULL
the	NULL
regulation	NULL
of	NULL
NF-	NULL
«	NULL
xB	NULL
by	NULL
the	NULL
ras	NULL
pathway	NULL
.	NULL

Cell	NULL
Death	NULL
and	NULL
Differentiation	NULL
fold	NULL
increase	NULL
3	NULL
10	NULL
2,5	NULL
3,5	NULL
AP-1	NULL
-	NULL
»	NULL
n	NULL
APC	NULL
H-2	NULL
k	NULL
b	NULL
b	NULL
k-	NULL
b	NULL
b	NULL
peptide	NULL
#	NULL
0	NULL
8	NULL
400	NULL
=	NULL
o	NULL
~	NULL
oot	NULL
littermate	NULL
dMek/dnRas	NULL
CD4+*CDS8t	NULL
fold	NULL
increase	NULL
3	NULL
1,5	NULL
1,5	NULL
NF-	NULL
«	NULL
xB	NULL
-	NULL
»	NULL
i	NULL
m	NULL
APC	NULL
H-2	NULL
k	NULL
k-	NULL
b	NULL
Ob	NULL
peptide	NULL
~	NULL
o	NULL
``	NULL
o	NULL
B	NULL
®	NULL
0	NULL
~	NULL
o	NULL
littermate	NULL
dMek/dnRas	NULL
CD4+CDS83*	NULL
Figure	NULL
2	NULL
DP	NULL
thymocytes	NULL
with	NULL
deficient	NULL
ras/Mek	NULL
pathway	NULL
induce	NULL
weak	NULL
AP-1	NULL
DNA	NULL
binding	NULL
activity	NULL
in	NULL
response	NULL
to	NULL
antigen	NULL
.	NULL

Purified	NULL
DP	NULL
thymocytes	NULL
from	NULL
K®-specific	NULL
KB5.C20-TCR	NULL
transgenic	NULL
mice	NULL
containing	NULL
the	NULL
transgene	NULL
for	NULL
the	NULL
dnras/	NULL
dMek	NULL
proteins	NULL
or	NULL
not	NULL
(	NULL
littermate	NULL
)	NULL
were	NULL
stimulated	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
irradiated	NULL
T	NULL
cell-depleted	NULL
APC	NULL
of	NULL
the	NULL
H-2	NULL
``	NULL
or	NULL
H-2	NULL
``	NULL
haplotype	NULL
for	NULL
18h	NULL
.	NULL

10	NULL
~	NULL
``	NULL
M	NULL
specific	NULL
antigenic	NULL
peptide	NULL
was	NULL
added	NULL
where	NULL
indicated	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
and	NULL
analyzed	NULL
by	NULL
gelshift	NULL
for	NULL
the	NULL
transcription	NULL
factors	NULL
AP-1	NULL
(	NULL
A	NULL
)	NULL
and	NULL
NF-xB	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Quantification	NULL
of	NULL
bands	NULL
was	NULL
performed	NULL
on	NULL
a	NULL
phosphor	NULL
plate	NULL
system	NULL
(	NULL
Fujix	NULL
Bas	NULL
1500	NULL
,	NULL
Fuji	NULL
,	NULL
Japan	NULL
)	NULL
.	NULL

A	NULL
control	NULL
gelshift	NULL
with	NULL
Oct-1	NULL
oligonucleotides	NULL
showed	NULL
similar	NULL
binding	NULL
activities	NULL
for	NULL
cell	NULL
extracts	NULL
from	NULL
mutant	NULL
and	NULL
littermate	NULL
mice	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
in	NULL
vitro	NULL
stimulation	NULL
and	NULL
subsequent	NULL
gelshift	NULL
was	NULL
repeated	NULL
four	NULL
times	NULL
with	NULL
the	NULL
same	NULL
results	NULL
as	NULL
those	NULL
shown	NULL
DP	NULL
thymocytes	NULL
do	NULL
not	NULL
intrinsically	NULL
lack	NULL
NF-	NULL
<	NULL
B	NULL
activity	NULL
As	NULL
expected	NULL
PMA/ionomycin	NULL
induced	NULL
transcriptional	NULL
activity	NULL
for	NULL
NF-kB	NULL
in	NULL
DP	NULL
thymocytes	NULL
.	NULL

This	NULL
confirmed	NULL
previous	NULL
results	NULL
obtained	NULL
using	NULL
gel	NULL
shift	NULL
assays	NULL
to	NULL
detect	NULL
DNA	NULL
binding	NULL
activity	NULL
for	NULL
NF-xB	NULL
°	NULL
and	NULL
shows	NULL
that	NULL
they	NULL
do	NULL
not	NULL
have	NULL
an	NULL
intrinsic	NULL
defect	NULL
in	NULL
mobilizing	NULL
NF-xB	NULL
transactivation	NULL
(	NULL
Figure	NULL
3B	NULL
)	NULL
.	NULL

It	NULL
is	NULL
generally	NULL
believed	NULL
that	NULL
the	NULL
ras/Mek	NULL
pathway	NULL
is	NULL
solicited	NULL
when	NULL
T	NULL
cells	NULL
are	NULL
stimulated	NULL
through	NULL
their	NULL
TCR	NULL
and	NULL
it	NULL
is	NULL
becoming	NULL
clear	NULL
that	NULL
phorbol	NULL
esters	NULL
are	NULL
also	NULL
very	NULL
effective	NULL
at	NULL
activating	NULL
ras	NULL
in	NULL
T	NULL
cell	NULL
lines	NULL
.	NULL
``	NULL

''	NULL
Our	NULL
results	NULL
show	NULL
that	NULL
the	NULL
induced	NULL
activity	NULL
of	NULL
NF-kB	NULL
in	NULL
DP	NULL
thymocytes	NULL
by	NULL
PMA¥/ionomycin	NULL
was	NULL
reduced	NULL
threefold	NULL
after	NULL
39	NULL
h	NULL
and	NULL
1.6-fold	NULL
after	NULL
53	NULL
h	NULL
of	NULL
stimulation	NULL
in	NULL
DP	NULL
thymocytes	NULL
expressing	NULL
dnras/dMek	NULL
(	NULL
Figure	NULL
3B	NULL
)	NULL
.	NULL

This	NULL
clearly	NULL
shows	NULL
the	NULL
activation	NULL
of	NULL
ras	NULL
by	NULL
phorbol	NULL
esters/ionomycin	NULL
in	NULL
these	NULL
cells	NULL
.	NULL

However	NULL
,	NULL
PMA/	NULL
lonomycin	NULL
failed	NULL
to	NULL
induce	NULL
AP-1	NULL
transactivation	NULL
in	NULL
DP	NULL
thymocytes	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
consistent	NULL
with	NULL
our	NULL
®	NULL
and	NULL
previous	NULL
``	NULL
®	NULL
results	NULL
using	NULL
gel	NULL
shift	NULL
assays	NULL
and	NULL
others	NULL
using	NULL
AP-1	NULL
lue	NULL
b	NULL
20	NULL
|	NULL
H-2K	NULL
H-2Kb	NULL
3	NULL
15	NULL
7	NULL
=	NULL
+peptide	NULL
A4	NULL
10	NULL
+	NULL
39h	NULL
5	NULL
L	NULL
B	NULL
2000	NULL
1500	NULL
-	NULL
C	NULL
ish	NULL
D	NULL
*	NULL
1000	NULL
{	NULL
39h	NULL
N	NULL
ssn	NULL
500	NULL
{	NULL
+	NULL
PMA/Ionomycin	NULL
DP	NULL
DP	NULL
Littermate	NULL
-	NULL
dnRas/dMek	NULL
Figure	NULL
3	NULL
-	NULL
(	NULL
A	NULL
)	NULL
DP	NULL
thymocytes	NULL
with	NULL
deficient	NULL
ras/Mek	NULL
pathway	NULL
induce	NULL
weak	NULL
AP-1	NULL
transcriptional	NULL
activity	NULL
in	NULL
response	NULL
to	NULL
antigen	NULL
.	NULL

DP	NULL
thymocytes	NULL
from	NULL
triple	NULL
transgenic	NULL
mice	NULL
(	NULL
TCRx	NULL
AP-1	NULL
luciferase	NULL
x	NULL
dnras/dMek	NULL
)	NULL
were	NULL
stimulated	NULL
for	NULL
39	NULL
h	NULL
with	NULL
antigen	NULL
and	NULL
analyzed	NULL
as	NULL
described	NULL
in	NULL
Figure	NULL
1	NULL
.	NULL

This	NULL
experiment	NULL
was	NULL
repeated	NULL
twice	NULL
with	NULL
similar	NULL
results	NULL
.	NULL

(	NULL
B	NULL
)	NULL
DP	NULL
thymocytes	NULL
with	NULL
deficient	NULL
ras/Mek	NULL
pathway	NULL
have	NULL
reduced	NULL
NF-kB	NULL
transcriptional	NULL
activity	NULL
in	NULL
response	NULL
to	NULL
PMA/	NULL
ionomycin	NULL
.	NULL

2x	NULL
10°	NULL
purified	NULL
DP	NULL
thymocytes	NULL
(	NULL
DP	NULL
)	NULL
from	NULL
triple	NULL
transgenic	NULL
mice	NULL
TCR	NULL
x	NULL
dnras/dMek	NULL
x	NULL
NF-xB	NULL
luciferase	NULL
or	NULL
TCR	NULL
x	NULL
dnras/dMek	NULL
x	NULL
AP-1	NULL
luciferase	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
PMA	NULL
plus	NULL
ionomycin	NULL
for	NULL
18	NULL
,	NULL
39	NULL
or	NULL
53h	NULL
.	NULL

Littermates	NULL
did	NULL
not	NULL
express	NULL
the	NULL
dnras/dMek	NULL
transgene	NULL
but	NULL
expressed	NULL
the	NULL
two	NULL
other	NULL
transgenes	NULL
.	NULL

Luciferase	NULL
activity	NULL
was	NULL
measured	NULL
in	NULL
the	NULL
cell	NULL
extracts	NULL
and	NULL
background	NULL
(	NULL
no	NULL
stimulation	NULL
)	NULL
was	NULL
substracted	NULL
from	NULL
values	NULL
.	NULL

The	NULL
experiments	NULL
shown	NULL
are	NULL
representative	NULL
experiments	NULL
out	NULL
of	NULL
three	NULL
the	NULL
same	NULL
reporter	NULL
In	NULL
total	NULL
thymocytes	NULL
,	NULL
both	NULL
PMA/lonomycin	NULL
and	NULL
antigen	NULL
induced	NULL
DNA	NULL
binding	NULL
of	NULL
the	NULL
p65/p50	NULL
complex	NULL
(	NULL
in	NULL
supershift	NULL
experiments	NULL
°	NULL
)	NULL
.	NULL

This	NULL
could	NULL
be	NULL
measured	NULL
3	NULL
h	NULL
after	NULL
stimulation	NULL
with	NULL
PMA/lonomycin	NULL
whereas	NULL
antigen	NULL
required	NULL
9	NULL
to	NULL
12	NULL
h	NULL
stimulation	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
there	NULL
is	NULL
no	NULL
qualitative	NULL
difference	NULL
but	NULL
only	NULL
a	NULL
kinetic	NULL
difference	NULL
between	NULL
the	NULL
two	NULL
stimulation	NULL
with	NULL
respect	NULL
to	NULL
induced	NULL
NF-	NULL
«	NULL
xB	NULL
complexes	NULL
.	NULL

In	NULL
summary	NULL
these	NULL
results	NULL
indicate	NULL
that	NULL
the	NULL
ras/Mek	NULL
pathway	NULL
is	NULL
functional	NULL
in	NULL
DP	NULL
thymocytes	NULL
as	NULL
the	NULL
transcriptional	NULL
activity	NULL
of	NULL
AP-1	NULL
and	NULL
NF-kB	NULL
seem	NULL
to	NULL
be	NULL
,	NULL
at	NULL
least	NULL
partially	NULL
,	NULL
under	NULL
its	NULL
control	NULL
.	NULL

This	NULL
suggests	NULL
that	NULL
another	NULL
upstream	NULL
signalling	NULL
pathway	NULL
is	NULL
responsible	NULL
for	NULL
the	NULL
failure	NULL
of	NULL
DP	NULL
thymocytes	NULL
to	NULL
activate	NULL
NF-kB	NULL
in	NULL
response	NULL
to	NULL
antigen	NULL
.	NULL

Lack	NULL
of	NULL
PKC	NULL
:	NULL
protein	NULL
in	NULL
preselection	NULL
CD4*CD8*	NULL
thymocytes	NULL
To	NULL
test	NULL
whether	NULL
DP	NULL
thymocytes	NULL
may	NULL
present	NULL
a	NULL
selective	NULL
defect	NULL
in	NULL
PKC	NULL
signalling	NULL
we	NULL
first	NULL
analyzed	NULL
the	NULL
expression	NULL
of	NULL
different	NULL
PKCs	NULL
in	NULL
preselection	NULL
DP	NULL
and	NULL
mature	NULL
CD8*	NULL
(	NULL
SPN	NULL
)	NULL
by	NULL
Western	NULL
blot	NULL
.	NULL

Western	NULL
blots	NULL
incubated	NULL
with	NULL
the	NULL
antiserum	NULL
obtained	NULL
from	NULL
Peter	NULL
Parker	NULL
show	NULL
that	NULL
DP	NULL
thymocytes	NULL
from	NULL
TCR	NULL
transgenic	NULL
mice	NULL
(	NULL
KB5.C20	NULL
)	NULL
are	NULL
deficient	NULL
in	NULL
PKCs	NULL
whereas	NULL
they	NULL
express	NULL
PKC	NULL
«	NULL
and	NULL
PKC	NULL
#	NULL
(	NULL
Figure	NULL
4A	NULL
)	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
the	NULL
«	NULL
and	NULL
B	NULL
isoforms	NULL
is	NULL
consistent	NULL
with	NULL
two	NULL
Lack	NULL
of	NULL
NF-kB	NULL
and	NULL
PKC	NULL
:	NULL
in	NULL
CD4*CD8*	NULL
thymocytes	NULL
AK	NULL
Simon	NULL
et	NULL
al	NULL
spLN	NULL
pp	NULL
PKCO	NULL
-_-	NULL
-	NULL
8SOkD	NULL
PKCﬁ	NULL
«	NULL
o	NULL
gig	NULL
-	NULL
80OkD	NULL
PKC	NULL
:	NULL
-	NULL
S0kD	NULL
DP	NULL
SP	NULL
SsPLN	NULL
pp	NULL
sp	NULL
sPLN	NULL
sp	NULL
~*~	NULL
__	NULL
N	NULL
C	NULL
-80kD	NULL
tc	NULL
...	NULL
Ai	NULL
PKCs	NULL
+peptide	NULL
Figure	NULL
4	NULL
Differential	NULL
expression	NULL
of	NULL
PKCa	NULL
,	NULL
PKC	NULL
and	NULL
PKCs	NULL
proteins	NULL
in	NULL
extracts	NULL
of	NULL
DP	NULL
versus	NULL
SP	NULL
thymocytes	NULL
and	NULL
lymph	NULL
node	NULL
T	NULL
cells	NULL
.	NULL

Cell	NULL
extracts	NULL
of	NULL
10	NULL
x	NULL
10°	NULL
preselection	NULL
DP	NULL
thymocytes	NULL
(	NULL
DP	NULL
)	NULL
,	NULL
thymic	NULL
CD8*	NULL
(	NULL
SP	NULL
)	NULL
or	NULL
mature	NULL
T	NULL
cells	NULL
from	NULL
lymph	NULL
nodes	NULL
(	NULL
SPLN	NULL
)	NULL
from	NULL
KB5.C20	NULL
mice	NULL
were	NULL
run	NULL
on	NULL
a	NULL
7-17	NULL
%	NULL
gradient	NULL
gel	NULL
,	NULL
blotted	NULL
and	NULL
incubated	NULL
with	NULL
the	NULL
antisera	NULL
obtained	NULL
from	NULL
Peter	NULL
Parker	NULL
.	NULL

(	NULL
A	NULL
)	NULL
PKC	NULL
#	NULL
and	NULL
$	NULL
but	NULL
not	NULL
PKCs	NULL
were	NULL
detected	NULL
in	NULL
preselection	NULL
DP	NULL
thymocytes	NULL
(	NULL
B	NULL
)	NULL
Low	NULL
expression	NULL
of	NULL
PKC	NULL
:	NULL
in	NULL
preselection	NULL
DP	NULL
and	NULL
SP	NULL
thymocytes	NULL
but	NULL
high	NULL
expression	NULL
of	NULL
PKCs	NULL
in	NULL
lymph	NULL
node	NULL
SP	NULL
T	NULL
cells	NULL
.	NULL

Method	NULL
as	NULL
in	NULL
A	NULL
but	NULL
specific	NULL
peptide	NULL
from	NULL
PKCs	NULL
was	NULL
added	NULL
prior	NULL
to	NULL
incubation	NULL
with	NULL
antiserum	NULL
against	NULL
PKCs	NULL
.	NULL

A	NULL
non-specific	NULL
band	NULL
was	NULL
detected	NULL
in	NULL
this	NULL
immunoblot	NULL
(	NULL
arrow	NULL
labelled	NULL
ns	NULL
)	NULL
.	NULL

In	NULL
left	NULL
panel	NULL
the	NULL
arrow	NULL
labelled	NULL
&	NULL
indicates	NULL
the	NULL
specific	NULL
band	NULL
for	NULL
PKCs	NULL
as	NULL
this	NULL
band	NULL
disappears	NULL
when	NULL
peptide	NULL
is	NULL
added	NULL
(	NULL
right	NULL
panel	NULL
)	NULL
.	NULL

Ponceau	NULL
S	NULL
staining	NULL
showed	NULL
equal	NULL
loading	NULL
of	NULL
protein	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
PKC	NULL
:	NULL
previous	NULL
reports	NULL
.	NULL
``	NULL

''	NULL
Peripheral	NULL
SP	NULL
T	NULL
cells	NULL
express	NULL
A	NULL
and	NULL
&	NULL
(	NULL
Figure	NULL
4A	NULL
)	NULL
.	NULL

Competition	NULL
with	NULL
a	NULL
specific	NULL
peptide	NULL
shows	NULL
that	NULL
the	NULL
PKCs	NULL
band	NULL
(	NULL
around	NULL
80	NULL
kD	NULL
)	NULL
is	NULL
specific	NULL
,	NULL
whereas	NULL
a	NULL
non-specific	NULL
band	NULL
(	NULL
ns	NULL
)	NULL
below	NULL
PKCz	NULL
(	NULL
i.e	NULL
.	NULL

not	NULL
competed	NULL
out	NULL
by	NULL
the	NULL
PKCz	NULL
-derived	NULL
peptide	NULL
)	NULL
is	NULL
also	NULL
revealed	NULL
(	NULL
Figure	NULL
4B	NULL
)	NULL
.	NULL

Thymic	NULL
CD8*	NULL
(	NULL
SP	NULL
)	NULL
express	NULL
an	NULL
intermediate	NULL
amount	NULL
of	NULL
PKCs	NULL
(	NULL
Figure	NULL
1257	NULL
Cell	NULL
Death	NULL
and	NULL
Differentiation	NULL
Lack	NULL
of	NULL
NF-xB	NULL
and	NULL
PKC	NULL
:	NULL
in	NULL
CD4*CD8*	NULL
thymocytes	NULL
AK	NULL
Simon	NULL
et	NULL
al	NULL
1258	NULL
4B	NULL
)	NULL
.	NULL

This	NULL
correlates	NULL
with	NULL
an	NULL
intermediate	NULL
amount	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
antigen-induced	NULL
cell	NULL
death	NULL
in	NULL
this	NULL
population	NULL
.	NULL

As	NULL
this	NULL
result	NULL
contradicts	NULL
two	NULL
other	NULL
studies	NULL
showing	NULL
that	NULL
PKCs	NULL
was	NULL
present	NULL
in	NULL
CD4*CD8*	NULL
thymocytes	NULL
,	NULL
**	NULL
?	NULL

we	NULL
extended	NULL
our	NULL
analysis	NULL
by	NULL
using	NULL
a	NULL
commercially	NULL
available	NULL
antiserum	NULL
(	NULL
Santa	NULL
Cruz	NULL
)	NULL
against	NULL
PKCsz	NULL
and	NULL
PKC	NULL
«	NULL
(	NULL
Figure	NULL
5	NULL
)	NULL
.	NULL

Both	NULL
antiserum	NULL
from	NULL
Peter	NULL
Parker	NULL
and	NULL
the	NULL
one	NULL
from	NULL
Santa	NULL
Cruz	NULL
were	NULL
raised	NULL
against	NULL
the	NULL
C-terminus	NULL
of	NULL
PKCs	NULL
and	NULL
showed	NULL
the	NULL
same	NULL
result	NULL
.	NULL

However	NULL
,	NULL
during	NULL
the	NULL
course	NULL
of	NULL
our	NULL
analysis	NULL
,	NULL
the	NULL
group	NULL
of	NULL
Ohaka	NULL
°°	NULL
published	NULL
a	NULL
study	NULL
which	NULL
contradicts	NULL
their	NULL
initial	NULL
observation	NULL
that	NULL
PKCs	NULL
was	NULL
predominantly	NULL
expressed	NULL
in	NULL
DP	NULL
thymocytes	NULL
,	NULL
since	NULL
they	NULL
observed	NULL
that	NULL
thymocytes	NULL
from	NULL
C57BL/6	NULL
mice	NULL
lack	NULL
PKCs	NULL
whereas	NULL
their	NULL
first	NULL
study	NULL
was	NULL
performed	NULL
on	NULL
Balb/c	NULL
.	NULL

Thus	NULL
to	NULL
test	NULL
whether	NULL
the	NULL
lack	NULL
of	NULL
PKCs	NULL
was	NULL
specific	NULL
of	NULL
the	NULL
TCR	NULL
transgenic	NULL
strain	NULL
KB5.C20	NULL
(	NULL
on	NULL
B10.BR	NULL
background	NULL
)	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
expression	NULL
of	NULL
PKCz	NULL
and	NULL
«	NULL
on	NULL
three	NULL
different	NULL
mouse	NULL
strains	NULL
including	NULL
normal	NULL
B10.BR	NULL
mice	NULL
,	NULL
transgenic	NULL
mice	NULL
expressing	NULL
a	NULL
TCR	NULL
restricted	NULL
by	NULL
MHC	NULL
class	NULL
II	NULL
(	NULL
HEL	NULL
)	NULL
(	NULL
on	NULL
a	NULL
CBA/J	NULL
background	NULL
)	NULL
,	NULL
and	NULL
transgenic	NULL
mice	NULL
expressing	NULL
a	NULL
TCR	NULL
restricted	NULL
by	NULL
class	NULL
|	NULL
(	NULL
KB5.C20	NULL
)	NULL
.	NULL

DP	NULL
thymocytes	NULL
from	NULL
all	NULL
mouse	NULL
strains	NULL
show	NULL
a	NULL
defect	NULL
in	NULL
PKCs	NULL
expression	NULL
(	NULL
Figure	NULL
5B	NULL
)	NULL
.	NULL

Peripheral	NULL
CD4*	NULL
cells	NULL
from	NULL
HEL	NULL
mice	NULL
,	NULL
CD8+*	NULL
from	NULL
KB5.C20	NULL
mice	NULL
or	NULL
CD4*	NULL
and	NULL
CD8+*	NULL
cells	NULL
from	NULL
B10.BR	NULL
all	NULL
expressed	NULL
PKCs	NULL
.	NULL

All	NULL
cell	NULL
populations	NULL
tested	NULL
were	NULL
positive	NULL
for	NULL
PKC	NULL
«	NULL
(	NULL
Figure	NULL
5B	NULL
)	NULL
.	NULL

Finally	NULL
to	NULL
determine	NULL
whether	NULL
the	NULL
discrepancy	NULL
between	NULL
our	NULL
results	NULL
and	NULL
those	NULL
of	NULL
others	NULL
was	NULL
due	NULL
to	NULL
the	NULL
preparation	NULL
of	NULL
the	NULL
extracts	NULL
,	NULL
we	NULL
followed	NULL
the	NULL
protocol	NULL
for	NULL
the	NULL
preparation	NULL
of	NULL
cytosolic	NULL
and	NULL
particulate	NULL
fractions	NULL
by	NULL
Strulovici	NULL
et	NULL
al	NULL
.	NULL
``	NULL

''	NULL
Particulate	NULL
and	NULL
cytosolic	NULL
fractions	NULL
of	NULL
preselection	NULL
DP	NULL
thymocytes	NULL
were	NULL
negative	NULL
for	NULL
PKCs	NULL
but	NULL
positive	NULL
for	NULL
PKC	NULL
«	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
confirming	NULL
our	NULL
previous	NULL
results	NULL
.	NULL

It	NULL
has	NULL
been	NULL
suggested	NULL
by	NULL
others	NULL
**	NULL
that	NULL
erroneous	NULL
detection	NULL
of	NULL
PKCz	NULL
could	NULL
be	NULL
due	NULL
to	NULL
cross-reactivity	NULL
of	NULL
putative	NULL
PKCs	NULL
antisera	NULL
with	NULL
PKC	NULL
»	NULL
since	NULL
the	NULL
protein	NULL
sequences	NULL
of	NULL
these	NULL
two	NULL
isoforms	NULL
are	NULL
similar	NULL
and	NULL
PKC	NULL
»	NULL
is	NULL
expressed	NULL
abundantly	NULL
in	NULL
thymus	NULL
,	NULL
normal	NULL
T	NULL
cells	NULL
and	NULL
T	NULL
cell	NULL
lines	NULL
.	NULL

We	NULL
conclude	NULL
that	NULL
preselection	NULL
DP	NULL
thymocytes	NULL
have	NULL
a	NULL
lower	NULL
expression	NULL
of	NULL
PKCs	NULL
than	NULL
peripheral	NULL
T	NULL
cells	NULL
(	NULL
this	NULL
comparison	NULL
was	NULL
never	NULL
shown	NULL
in	NULL
any	NULL
previous	NULL
study	NULL
)	NULL
and	NULL
that	NULL
its	NULL
expression	NULL
is	NULL
regulated	NULL
during	NULL
thymic	NULL
development	NULL
,	NULL
mouse	NULL
strain	NULL
-	NULL
B1I0OBR	NULL
C20	NULL
HEL	NULL
B10BR	NULL
C20	NULL
HEL	NULL
Figure	NULL
5	NULL
Lack	NULL
of	NULL
PKCs	NULL
in	NULL
immature	NULL
DP	NULL
thymocytes	NULL
in	NULL
different	NULL
mouse	NULL
strains	NULL
.	NULL

Western	NULL
blot	NULL
(	NULL
7	NULL
%	NULL
acrylamide	NULL
)	NULL
of	NULL
lysates	NULL
of	NULL
5x	NULL
10°	NULL
immature	NULL
DP	NULL
thymocytes	NULL
(	NULL
D	NULL
)	NULL
or	NULL
lymph	NULL
node	NULL
SP	NULL
T	NULL
cells	NULL
(	NULL
S	NULL
)	NULL
from	NULL
indicated	NULL
mouse	NULL
strains	NULL
.	NULL

Lymph	NULL
node	NULL
SP	NULL
T	NULL
cells	NULL
from	NULL
B10.BR	NULL
mice	NULL
were	NULL
a	NULL
mixed	NULL
population	NULL
of	NULL
CD4*	NULL
and	NULL
CD8+*	NULL
cells	NULL
whereas	NULL
SP	NULL
T	NULL
cells	NULL
from	NULL
KB5.C20	NULL
(	NULL
C20	NULL
)	NULL
or	NULL
HEL	NULL
TCR	NULL
transgenic	NULL
mice	NULL
were	NULL
either	NULL
CD8*	NULL
or	NULL
CD4*	NULL
cells	NULL
,	NULL
respectively	NULL
.	NULL

(	NULL
A	NULL
)	NULL
The	NULL
immunoblot	NULL
was	NULL
incubated	NULL
with	NULL
anti-PKC	NULL
#	NULL
antiserum	NULL
(	NULL
Santa	NULL
Cruz	NULL
)	NULL
.	NULL

(	NULL
B	NULL
)	NULL
The	NULL
immunoblot	NULL
was	NULL
incubated	NULL
with	NULL
anti-PKCs	NULL
antiserum	NULL
(	NULL
Santa	NULL
Cruz	NULL
)	NULL
Cell	NULL
Death	NULL
and	NULL
Differentiation	NULL
as	NULL
DN	NULL
express	NULL
a	NULL
low	NULL
amount	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
preselection	NULL
DP	NULL
are	NULL
deficient	NULL
and	NULL
thymic	NULL
SP	NULL
upregulate	NULL
PKCsz	NULL
expression	NULL
.	NULL

Discussion	NULL
Death	NULL
correlates	NULL
with	NULL
lack	NULL
of	NULL
NF-xB	NULL
transcriptional	NULL
activity	NULL
during	NULL
thymic	NULL
development	NULL
Using	NULL
mice	NULL
transgenic	NULL
for	NULL
a	NULL
TCR	NULL
and	NULL
for	NULL
a	NULL
reporter	NULL
gene	NULL
construct	NULL
controlled	NULL
by	NULL
either	NULL
NF-	NULL
«	NULL
B	NULL
or	NULL
AP-1	NULL
binding	NULL
sites	NULL
,	NULL
we	NULL
show	NULL
that	NULL
there	NULL
is	NULL
a	NULL
lack	NULL
of	NULL
NF-xB	NULL
transactivation	NULL
after	NULL
in	NULL
vitro	NULL
stimulation	NULL
with	NULL
antigen	NULL
of	NULL
immature	NULL
DP	NULL
thymocytes	NULL
whereas	NULL
AP-1	NULL
is	NULL
transcriptionally	NULL
active	NULL
.	NULL

Our	NULL
results	NULL
show	NULL
that	NULL
as	NULL
thymocytes	NULL
become	NULL
less	NULL
susceptible	NULL
to	NULL
antigen-induced	NULL
death	NULL
when	NULL
they	NULL
mature	NULL
from	NULL
DP	NULL
to	NULL
thymic	NULL
SP	NULL
and	NULL
peripheral	NULL
SP	NULL
CD8	NULL
cells	NULL
,	NULL
NF-xB	NULL
activity	NULL
increases	NULL
inversely	NULL
.	NULL

Thus	NULL
the	NULL
agonist	NULL
responsible	NULL
for	NULL
negative	NULL
selection	NULL
events	NULL
in	NULL
DP	NULL
thymocytes	NULL
activates	NULL
AP-1	NULL
transactivation	NULL
but	NULL
fails	NULL
to	NULL
induce	NULL
the	NULL
'survival	NULL
transcription	NULL
factor	NULL
NF-kB	NULL
.	NULL

Pharmacological	NULL
stimuli	NULL
,	NULL
however	NULL
showed	NULL
that	NULL
thymocytes	NULL
at	NULL
this	NULL
stage	NULL
do	NULL
not	NULL
have	NULL
an	NULL
intrinsic	NULL
defect	NULL
in	NULL
NF-kB	NULL
induction	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
NF-xB	NULL
after	NULL
antigenic	NULL
stimulation	NULL
is	NULL
particularly	NULL
interesting	NULL
as	NULL
NF-kB	NULL
was	NULL
shown	NULL
to	NULL
be	NULL
a	NULL
'survival	NULL
transcription	NULL
factor	NULL
.	NULL

A	NULL
T	NULL
cell	NULL
hybridoma	NULL
was	NULL
rendered	NULL
more	NULL
susceptible	NULL
to	NULL
TCR-induced	NULL
apoptosis	NULL
through	NULL
inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
a	NULL
soluble	NULL
peptide	NULL
inhibitor	NULL
.	NULL

Correspondingly	NULL
,	NULL
transfection	NULL
of	NULL
p50	NULL
and	NULL
p65	NULL
provided	NULL
considerable	NULL
protection	NULL
from	NULL
TCR-induced	NULL
apoptosis	NULL
in	NULL
these	NULL
cells	NULL
.	NULL
``	NULL

''	NULL
Similarly	NULL
to	NULL
our	NULL
results	NULL
with	NULL
antigen	NULL
,	NULL
NF-xB	NULL
is	NULL
downmodulated	NULL
in	NULL
thymocytes	NULL
in	NULL
response	NULL
to	NULL
in	NULL
vivo	NULL
injection	NULL
of	NULL
glucocorticoids	NULL
preceding	NULL
death	NULL
.	NULL

Induction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
diminished	NULL
dexamethasone-induced	NULL
thymocyte	NULL
death	NULL
.	NULL
``	NULL

''	NULL
However	NULL
,	NULL
in	NULL
a	NULL
transgenic	NULL
mouse	NULL
model	NULL
where	NULL
NF-kB	NULL
is	NULL
constitutively	NULL
inhibited	NULL
by	NULL
a	NULL
superinhibitory	NULL
IxB-	NULL
«	NULL
protein	NULL
,	NULL
anti-CD3	NULL
induced	NULL
death	NULL
in	NULL
thymocytes	NULL
in	NULL
vivo	NULL
is	NULL
inhibited	NULL
.	NULL
``	NULL

The	NULL
discrepancy	NULL
between	NULL
this	NULL
result	NULL
and	NULL
ours	NULL
could	NULL
be	NULL
due	NULL
to	NULL
differential	NULL
signalling	NULL
in	NULL
response	NULL
to	NULL
anti-CD3	NULL
and	NULL
antigen+APC	NULL
.	NULL

``	NULL
°	NULL
Whether	NULL
overexpression	NULL
of	NULL
NF-xB	NULL
can	NULL
rescue	NULL
thymocytes	NULL
from	NULL
TCR-mediated	NULL
death	NULL
and	NULL
lead	NULL
to	NULL
the	NULL
emergence	NULL
of	NULL
autoreactive	NULL
T	NULL
cells	NULL
has	NULL
yet	NULL
to	NULL
be	NULL
shown	NULL
.	NULL

Furthermore	NULL
it	NULL
is	NULL
not	NULL
clear	NULL
whether	NULL
TCR-mediated	NULL
signals	NULL
only	NULL
sensitise	NULL
DP	NULL
thymocytes	NULL
to	NULL
apoptotic	NULL
stimuli	NULL
provided	NULL
by	NULL
other	NULL
receptors	NULL
like	NULL
members	NULL
of	NULL
the	NULL
TNF	NULL
receptor	NULL
family	NULL
.	NULL
``	NULL

''	NULL
This	NULL
sensitisation	NULL
to	NULL
apoptosis	NULL
could	NULL
partly	NULL
be	NULL
due	NULL
to	NULL
a	NULL
lack	NULL
of	NULL
NF-kB	NULL
.	NULL

Thus	NULL
,	NULL
TNF	NULL
stimulated	NULL
anti-death	NULL
activity	NULL
appears	NULL
to	NULL
be	NULL
mediated	NULL
by	NULL
the	NULL
NF-xB	NULL
family	NULL
(	NULL
or	NULL
reviewed	NULL
in	NULL
°°	NULL
)	NULL
.	NULL

In	NULL
B	NULL
lymphocytes	NULL
NF-kB	NULL
mediated	NULL
upregulation	NULL
of	NULL
Bcl-x	NULL
is	NULL
required	NULL
for	NULL
CD40	NULL
survival	NULL
signalling	NULL
.	NULL
}	NULL

®	NULL
In	NULL
a	NULL
transgenic	NULL
mouse	NULL
model	NULL
of	NULL
CD30	NULL
overexpression	NULL
in	NULL
the	NULL
T	NULL
cell	NULL
lineage	NULL
,	NULL
apoptosis	NULL
can	NULL
be	NULL
induced	NULL
in	NULL
thymocytes	NULL
when	NULL
TCR	NULL
and	NULL
CD30	NULL
are	NULL
simultaneously	NULL
engaged	NULL
.	NULL

This	NULL
engagement	NULL
does	NULL
not	NULL
induce	NULL
NF-xB	NULL
and	NULL
can	NULL
be	NULL
inhibited	NULL
by	NULL
Bel-2	NULL
.	NULL
``	NULL

''	NULL
Taken	NULL
together	NULL
our	NULL
results	NULL
suggest	NULL
that	NULL
the	NULL
lack	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activity	NULL
in	NULL
response	NULL
to	NULL
antigen	NULL
in	NULL
DP	NULL
thymocytes	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
susceptibility	NULL
of	NULL
DP	NULL
thymocytes	NULL
to	NULL
death	NULL
.	NULL

Our	NULL
finding	NULL
of	NULL
the	NULL
lack	NULL
of	NULL
NF-kB	NULL
activity	NULL
has	NULL
been	NULL
confirmed	NULL
in	NULL
two	NULL
different	NULL
experimental	NULL
systems	NULL
,	NULL
one	NULL
revealing	NULL
DNA	NULL
binding	NULL
activity	NULL
of	NULL
transcription	NULL
factors	NULL
(	NULL
this	NULL
study	NULL
and	NULL
°	NULL
)	NULL
and	NULL
the	NULL
other	NULL
one	NULL
using	NULL
luciferase	NULL
reporter	NULL
mice	NULL
detecting	NULL
transactivation	NULL
.	NULL

This	NULL
is	NULL
particularly	NULL
important	NULL
as	NULL
it	NULL
was	NULL
shown	NULL
that	NULL
DNA-binding	NULL
is	NULL
not	NULL
always	NULL
sufficient	NULL
to	NULL
induce	NULL
transcriptional	NULL
activity	NULL
and	NULL
that	NULL
the	NULL
two	NULL
events	NULL
can	NULL
be	NULL
regulated	NULL
at	NULL
different	NULL
levels	NULL
.	NULL

Thus	NULL
,	NULL
degradation	NULL
of	NULL
IxBa	NULL
not	NULL
only	NULL
releases	NULL
NF-kB	NULL
,	NULL
permits	NULL
its	NULL
translocation	NULL
to	NULL
the	NULL
nucleus	NULL
and	NULL
binding	NULL
to	NULL
DNA	NULL
but	NULL
also	NULL
releases	NULL
and	NULL
activates	NULL
the	NULL
catalytic	NULL
unit	NULL
of	NULL
protein	NULL
kinase	NULL
A	NULL
(	NULL
PKAc	NULL
)	NULL
.	NULL

PKAc	NULL
phosphorylates	NULL
the	NULL
subunit	NULL
p65	NULL
of	NULL
NF-kB	NULL
and	NULL
increases	NULL
transactivation	NULL
whereas	NULL
the	NULL
DNA-binding	NULL
is	NULL
not	NULL
affected	NULL
by	NULL
this	NULL
phosphorylation	NULL
step	NULL
.	NULL

``	NULL
®	NULL
The	NULL
transcriptional	NULL
activity	NULL
of	NULL
NF-xB	NULL
is	NULL
thus	NULL
regulated	NULL
at	NULL
two	NULL
levels	NULL
(	NULL
i	NULL
)	NULL
its	NULL
release	NULL
from	NULL
cytosolic	NULL
complexes	NULL
with	NULL
IxB	NULL
and	NULL
(	NULL
ii	NULL
)	NULL
its	NULL
phosphorylation	NULL
by	NULL
PKA	NULL
.	NULL

Such	NULL
a	NULL
layering	NULL
of	NULL
regulatory	NULL
mechanisms	NULL
could	NULL
contribute	NULL
to	NULL
fine	NULL
tuning	NULL
the	NULL
expression	NULL
of	NULL
genes	NULL
regulated	NULL
by	NULL
NF-xB	NULL
,	NULL
especially	NULL
if	NULL
the	NULL
two	NULL
mechanisms	NULL
were	NULL
targeted	NULL
differentially	NULL
by	NULL
upstream	NULL
signals	NULL
.	NULL

In	NULL
our	NULL
study	NULL
,	NULL
transactivation	NULL
and	NULL
DNA-binding	NULL
activity	NULL
of	NULL
AP-1	NULL
seem	NULL
to	NULL
correlate	NULL
very	NULL
well	NULL
.	NULL

However	NULL
,	NULL
after	NULL
antigenic	NULL
stimulation	NULL
in	NULL
DP	NULL
thymocytes	NULL
some	NULL
low	NULL
level	NULL
NF-kB	NULL
DNA-binding	NULL
was	NULL
detected	NULL
without	NULL
transcriptional	NULL
activity	NULL
suggesting	NULL
that	NULL
the	NULL
pathway	NULL
activating	NULL
the	NULL
regulatory	NULL
mechanism	NULL
for	NULL
transactivation	NULL
had	NULL
not	NULL
been	NULL
induced	NULL
.	NULL

It	NULL
would	NULL
be	NULL
of	NULL
interest	NULL
to	NULL
determine	NULL
whether	NULL
such	NULL
a	NULL
mechanism	NULL
could	NULL
contribute	NULL
to	NULL
survival	NULL
or	NULL
death	NULL
in	NULL
thymic	NULL
selection	NULL
processes	NULL
.	NULL

However	NULL
,	NULL
we	NULL
show	NULL
that	NULL
DP	NULL
thymocytes	NULL
are	NULL
not	NULL
intrinsically	NULL
deficient	NULL
in	NULL
NF-kB	NULL
as	NULL
phorbol	NULL
ester/ionophore	NULL
stimulate	NULL
NF-kB	NULL
transcriptional	NULL
activity	NULL
.	NULL

In	NULL
the	NULL
system	NULL
described	NULL
here	NULL
,	NULL
PMA/ionomycin	NULL
induces	NULL
death	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
although	NULL
NF-kB	NULL
transcriptional	NULL
activity	NULL
is	NULL
present	NULL
.	NULL

Thus	NULL
only	NULL
antigen-specific	NULL
deletion	NULL
may	NULL
be	NULL
affected	NULL
by	NULL
the	NULL
defect	NULL
in	NULL
NF-kB	NULL
transactivation	NULL
.	NULL

This	NULL
contradiction	NULL
can	NULL
be	NULL
explained	NULL
by	NULL
the	NULL
fact	NULL
that	NULL
PMA¥/ionomycin	NULL
and	NULL
antigen	NULL
use	NULL
a	NULL
very	NULL
different	NULL
set	NULL
of	NULL
signalling	NULL
molecules	NULL
.	NULL

Indeed	NULL
,	NULL
in	NULL
thymus	NULL
organ	NULL
cultures	NULL
phorbol	NULL
esters/ionophores	NULL
cause	NULL
downregulation	NULL
of	NULL
CD4	NULL
alone	NULL
as	NULL
opposed	NULL
to	NULL
downregulation	NULL
of	NULL
both	NULL
coreceptors	NULL
induced	NULL
by	NULL
antigen	NULL
.	NULL

``	NULL
°	NULL
Furthermore	NULL
phorbol	NULL
ester/ionophores	NULL
do	NULL
not	NULL
induce	NULL
death	NULL
in	NULL
thymic	NULL
organs	NULL
whereas	NULL
antigen	NULL
does	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
and	NULL
°°	NULL
)	NULL
.	NULL

Our	NULL
findings	NULL
concerning	NULL
the	NULL
selective	NULL
defect	NULL
in	NULL
PKCs	NULL
in	NULL
DP	NULL
thymocytes	NULL
could	NULL
account	NULL
for	NULL
the	NULL
lack	NULL
of	NULL
NF-kB	NULL
activity	NULL
in	NULL
response	NULL
to	NULL
antigen	NULL
as	NULL
phorbol	NULL
esters/ionophores	NULL
may	NULL
use	NULL
other	NULL
PKC	NULL
isoforms	NULL
to	NULL
signal	NULL
.	NULL

Transactivation	NULL
of	NULL
AP-1	NULL
by	NULL
antigen	NULL
and	NULL
of	NULL
NF-xB	NULL
by	NULL
phorbol	NULL
ester/ionophore	NULL
are	NULL
partly	NULL
controlled	NULL
by	NULL
the	NULL
ras/Mek	NULL
pathway	NULL
in	NULL
DP	NULL
thymocytes	NULL
The	NULL
AP-1	NULL
transcription	NULL
factor	NULL
is	NULL
composed	NULL
of	NULL
proteins	NULL
of	NULL
the	NULL
c-jun	NULL
and	NULL
c-fos	NULL
family	NULL
.	NULL

Phosphorylation	NULL
of	NULL
N-terminal	NULL
serines	NULL
of	NULL
c-jun	NULL
by	NULL
a	NULL
protein	NULL
kinase	NULL
termed	NULL
JNK	NULL
(	NULL
Jun	NULL
kinase	NULL
)	NULL
has	NULL
been	NULL
shown	NULL
to	NULL
increase	NULL
transcription	NULL
without	NULL
affecting	NULL
DNA-binding	NULL
(	NULL
reviewed	NULL
in	NULL
*	NULL
``	NULL
)	NULL
.	NULL

The	NULL
JNK	NULL
isoforms	NULL
are	NULL
members	NULL
of	NULL
the	NULL
MAPK	NULL
family	NULL
,	NULL
like	NULL
ERK1	NULL
and	NULL
ERK2	NULL
(	NULL
extracellular	NULL
signal	NULL
regulated	NULL
protein	NULL
kinase	NULL
)	NULL
.	NULL

Both	NULL
the	NULL
ERKs	NULL
and	NULL
JNKs	NULL
are	NULL
activated	NULL
by	NULL
oncogenic	NULL
H-ras	NULL
.	NULL

Ras	NULL
activation	NULL
triggers	NULL
two	NULL
divergent	NULL
signalling	NULL
cascades	NULL
that	NULL
activate	NULL
distinct	NULL
MAPKs	NULL
.	NULL

One	NULL
is	NULL
initiated	NULL
by	NULL
rafi	NULL
leading	NULL
to	NULL
Mek-1	NULL
(	NULL
MAPK/ERK	NULL
kinase	NULL
)	NULL
and	NULL
Lack	NULL
of	NULL
NF-kB	NULL
and	NULL
PKC	NULL
:	NULL
in	NULL
CD4*CD8*	NULL
thymocytes	NULL
AK	NULL
Simon	NULL
et	NULL
al	NULL
Mek-2	NULL
and	NULL
then	NULL
ERK1	NULL
and	NULL
ERK2	NULL
activation	NULL
that	NULL
phosphor-ylate	NULL
and	NULL
potentiate	NULL
the	NULL
activity	NULL
of	NULL
TCF/Elk-1	NULL
and	NULL
thereby	NULL
induce	NULL
c-fos	NULL
.	NULL
``	NULL

The	NULL
other	NULL
one	NULL
is	NULL
initiated	NULL
by	NULL
MEKK	NULL
leading	NULL
to	NULL
JNK	NULL
activation	NULL
that	NULL
phosphorylates	NULL
and	NULL
potentiates	NULL
the	NULL
activity	NULL
of	NULL
c-jun	NULL
.	NULL

*	NULL
'	NULL
The	NULL
mice	NULL
used	NULL
in	NULL
this	NULL
study	NULL
express	NULL
a	NULL
dominant-negative	NULL
mutant	NULL
of	NULL
ras	NULL
,	NULL
as	NULL
well	NULL
as	NULL
a	NULL
catalytically	NULL
inactive	NULL
form	NULL
of	NULL
Mek-1	NULL
.	NULL

Unexpectedly	NULL
we	NULL
found	NULL
the	NULL
transcription	NULL
of	NULL
AP-1	NULL
only	NULL
partly	NULL
inhibited	NULL
by	NULL
the	NULL
transdominant	NULL
proteins	NULL
.	NULL

This	NULL
may	NULL
be	NULL
either	NULL
because	NULL
the	NULL
dominant-negative	NULL
proteins	NULL
are	NULL
not	NULL
sufficiently	NULL
expressed	NULL
or	NULL
because	NULL
a	NULL
ras-independent	NULL
signalling	NULL
pathway	NULL
for	NULL
AP-1	NULL
exists	NULL
.	NULL

The	NULL
fact	NULL
that	NULL
proliferation	NULL
and	NULL
CD69	NULL
expression	NULL
is	NULL
only	NULL
partly	NULL
inhibited	NULL
in	NULL
thymocytes	NULL
from	NULL
dnras/dMek	NULL
expressing	NULL
mice	NULL
favours	NULL
the	NULL
first	NULL
explanation	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

On	NULL
the	NULL
other	NULL
hand	NULL
selective	NULL
inhibition	NULL
of	NULL
PKCs	NULL
inhibits	NULL
IL-2	NULL
expression	NULL
in	NULL
a	NULL
human	NULL
T	NULL
cell	NULL
line	NULL
without	NULL
affecting	NULL
ras-induced	NULL
AP-1	NULL
activation	NULL
suggesting	NULL
a	NULL
parallel	NULL
pathway	NULL
.	NULL
``	NULL

This	NULL
is	NULL
,	NULL
however	NULL
,	NULL
contradicted	NULL
in	NULL
the	NULL
case	NULL
of	NULL
DP	NULL
thymocytes	NULL
(	NULL
this	NULL
study	NULL
and	NULL
*	NULL
``	NULL
)	NULL
where	NULL
activation	NULL
with	NULL
PMA	NULL
,	NULL
a	NULL
potent	NULL
stimulator	NULL
of	NULL
PKCs	NULL
,	NULL
or	NULL
even	NULL
PMA	NULL
in	NULL
combination	NULL
with	NULL
ionomycin	NULL
does	NULL
not	NULL
induce	NULL
AP-1	NULL
.	NULL

It	NULL
suggests	NULL
that	NULL
AP-1	NULL
activity	NULL
after	NULL
antigenic	NULL
stimulation	NULL
in	NULL
DP	NULL
thymocytes	NULL
is	NULL
probably	NULL
under	NULL
the	NULL
control	NULL
of	NULL
ras	NULL
.	NULL

Furthermore	NULL
it	NULL
was	NULL
suggested	NULL
that	NULL
the	NULL
dnras/dMek	NULL
mice	NULL
have	NULL
an	NULL
impaired	NULL
positive	NULL
selection	NULL
in	NULL
the	NULL
thymus	NULL
but	NULL
show	NULL
no	NULL
defect	NULL
in	NULL
negative	NULL
selection	NULL
.	NULL
``	NULL

Together	NULL
with	NULL
our	NULL
data	NULL
showing	NULL
the	NULL
partial	NULL
control	NULL
of	NULL
AP-1	NULL
by	NULL
this	NULL
signalling	NULL
pathway	NULL
,	NULL
it	NULL
may	NULL
indicate	NULL
that	NULL
AP-1	NULL
could	NULL
be	NULL
an	NULL
important	NULL
transcription	NULL
factor	NULL
in	NULL
positive	NULL
selection	NULL
events	NULL
that	NULL
would	NULL
not	NULL
contribute	NULL
to	NULL
negative	NULL
selection	NULL
.	NULL

Concerning	NULL
the	NULL
control	NULL
of	NULL
NF-xB	NULL
by	NULL
the	NULL
ras/Mek	NULL
pathway	NULL
our	NULL
data	NULL
suggests	NULL
that	NULL
the	NULL
lack	NULL
of	NULL
NF-kB	NULL
in	NULL
DP	NULL
thymocytes	NULL
in	NULL
response	NULL
to	NULL
antigen	NULL
is	NULL
not	NULL
due	NULL
to	NULL
the	NULL
absence	NULL
of	NULL
ras	NULL
signalling	NULL
since	NULL
this	NULL
pathway	NULL
is	NULL
functional	NULL
for	NULL
AP-1	NULL
signalling	NULL
.	NULL

However	NULL
,	NULL
phorbol	NULL
ester	NULL
activates	NULL
the	NULL
ras	NULL
pathway	NULL
for	NULL
NF-xB	NULL
activity	NULL
,	NULL
probably	NULL
via	NULL
PKCs	NULL
.	NULL

In	NULL
T	NULL
cells	NULL
it	NULL
has	NULL
been	NULL
shown	NULL
that	NULL
some	NULL
of	NULL
the	NULL
effects	NULL
of	NULL
phorbol	NULL
esters	NULL
previously	NULL
attributed	NULL
to	NULL
PKCs	NULL
alone	NULL
are	NULL
also	NULL
ras-mediated	NULL
.	NULL

``	NULL
>	NULL
On	NULL
the	NULL
other	NULL
hand	NULL
,	NULL
antigen	NULL
presented	NULL
on	NULL
APCs	NULL
does	NULL
not	NULL
induce	NULL
the	NULL
activity	NULL
of	NULL
NF-xB	NULL
in	NULL
DP	NULL
thymocytes	NULL
.	NULL

It	NULL
is	NULL
possible	NULL
that	NULL
distinct	NULL
PKCs	NULL
are	NULL
required	NULL
after	NULL
TCR	NULL
engagement	NULL
and	NULL
PMA/ionomycin	NULL
stimulation	NULL
in	NULL
DP	NULL
thymocytes	NULL
.	NULL

This	NULL
hypothesis	NULL
is	NULL
further	NULL
supported	NULL
by	NULL
our	NULL
finding	NULL
that	NULL
preselection	NULL
DP	NULL
thymocytes	NULL
lack	NULL
PKCs	NULL
protein	NULL
whereas	NULL
CD4~CD8~	NULL
and	NULL
mature	NULL
peripheral	NULL
T	NULL
cells	NULL
express	NULL
PKCs	NULL
at	NULL
high	NULL
levels	NULL
.	NULL

Lack	NULL
of	NULL
PKC	NULL
:	NULL
in	NULL
DP	NULL
thymocytes	NULL
This	NULL
study	NULL
shows	NULL
a	NULL
lack	NULL
of	NULL
PKCz	NULL
but	NULL
not	NULL
of	NULL
PKCa	NULL
«	NULL
nor	NULL
PKC	NULL
$	NULL
in	NULL
DP	NULL
thymocytes	NULL
.	NULL

Furthermore	NULL
thymic	NULL
SP	NULL
express	NULL
intermediate	NULL
amounts	NULL
of	NULL
PKCs	NULL
and	NULL
peripheral	NULL
T	NULL
cells	NULL
have	NULL
a	NULL
comparable	NULL
high	NULL
level	NULL
of	NULL
PKCs	NULL
and	NULL
PKCa	NULL
«	NULL
expression	NULL
.	NULL

The	NULL
family	NULL
of	NULL
PKCs	NULL
consists	NULL
of	NULL
isozymes	NULL
that	NULL
have	NULL
been	NULL
categorised	NULL
into	NULL
three	NULL
classes	NULL
:	NULL
conventional	NULL
PKCs	NULL
(	NULL
«	NULL
and	NULL
$	NULL
)	NULL
which	NULL
are	NULL
regulated	NULL
by	NULL
diacylglycerol	NULL
,	NULL
phosphatidylserine	NULL
and	NULL
Ca**	NULL
,	NULL
novel	NULL
PKCs	NULL
(	NULL
8	NULL
,	NULL
&	NULL
,	NULL
7	NULL
,	NULL
0	NULL
)	NULL
which	NULL
are	NULL
regulated	NULL
only	NULL
by	NULL
diacylglycerol	NULL
and	NULL
phosphatidylserine	NULL
,	NULL
and	NULL
atypical	NULL
PKCs	NULL
(	NULL
{	NULL
,	NULL
t	NULL
and	NULL
2	NULL
)	NULL
whose	NULL
regulation	NULL
has	NULL
not	NULL
been	NULL
clearly	NULL
established	NULL
,	NULL
although	NULL
their	NULL
activity	NULL
is	NULL
stimulated	NULL
by	NULL
phosphatidylserine	NULL
.	NULL

Phorbol	NULL
esters	NULL
can	NULL
substitute	NULL
for	NULL
1259	NULL
Cell	NULL
Death	NULL
and	NULL
Differentiation	NULL
Lack	NULL
of	NULL
NF-xB	NULL
and	NULL
PKC	NULL
:	NULL
in	NULL
CD4*CD8*	NULL
thymocytes	NULL
AK	NULL
Simon	NULL
et	NULL
al	NULL
1260	NULL
diacylglycerol	NULL
and	NULL
activate	NULL
all	NULL
the	NULL
PKCs	NULL
except	NULL
the	NULL
atypical	NULL
PKCs	NULL
.	NULL

Since	NULL
phorbol	NULL
esters	NULL
alone	NULL
or	NULL
in	NULL
conjunction	NULL
with	NULL
Ca*+*	NULL
ionophores	NULL
are	NULL
capable	NULL
of	NULL
inducing	NULL
many	NULL
differentiated	NULL
functions	NULL
of	NULL
T	NULL
lymphocytes	NULL
,	NULL
it	NULL
is	NULL
evident	NULL
that	NULL
PKCs	NULL
play	NULL
an	NULL
important	NULL
role	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
T	NULL
cells	NULL
(	NULL
reviewed	NULL
in	NULL
'	NULL
``	NULL
)	NULL
.	NULL

Studies	NULL
on	NULL
the	NULL
expression	NULL
of	NULL
different	NULL
isotypes	NULL
detected	NULL
mRNA	NULL
for	NULL
PKCa	NULL
,	NULL
$	NULL
,	NULL
¢	NULL
,	NULL
s	NULL
and	NULL
most	NULL
abundantly	NULL
7	NULL
and	NULL
0	NULL
in	NULL
mouse	NULL
T	NULL
cells	NULL
and	NULL
T	NULL
cell	NULL
lines	NULL
.	NULL

``	NULL
``	NULL
*~	NULL
``	NULL
°	NULL
PKC	NULL
0	NULL
is	NULL
thought	NULL
to	NULL
play	NULL
a	NULL
special	NULL
role	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
**	NULL
and	NULL
cell	NULL
death	NULL
via	NULL
induction	NULL
of	NULL
Fas	NULL
ligand	NULL
.	NULL
``	NULL

However	NULL
,	NULL
in	NULL
one	NULL
study	NULL
PKC	NULL
0	NULL
does	NULL
not	NULL
activate	NULL
NF-kB	NULL
or	NULL
NF-AT	NULL
in	NULL
T	NULL
lymphocytes	NULL
but	NULL
rather	NULL
AP-1	NULL
.	NULL

*°	NULL
Furthermore	NULL
it	NULL
is	NULL
present	NULL
abundantly	NULL
in	NULL
thymocytes	NULL
.	NULL

``	NULL
°	NULL
A	NULL
more	NULL
recent	NULL
study	NULL
using	NULL
PKCO	NULL
deficient	NULL
mouse	NULL
shows	NULL
that	NULL
PKCO	NULL
is	NULL
necessary	NULL
for	NULL
activation	NULL
of	NULL
NF-xB	NULL
by	NULL
anti-CD3	NULL
in	NULL
mature	NULL
lymphocytes	NULL
but	NULL
not	NULL
immature	NULL
lymphocytes	NULL
.	NULL

``	NULL
°	NULL
In	NULL
the	NULL
human	NULL
T	NULL
cell	NULL
line	NULL
Jurkat	NULL
,	NULL
transfection	NULL
of	NULL
constitutively	NULL
active	NULL
PKCs	NULL
shows	NULL
that	NULL
PKCs	NULL
and	NULL
to	NULL
a	NULL
lesser	NULL
extent	NULL
PKCa	NULL
,	NULL
but	NULL
not	NULL
can	NULL
regulate	NULL
the	NULL
transcription	NULL
factors	NULL
NF-AT	NULL
and	NULL
AP-1.°	NULL
NF-xB	NULL
transactivation	NULL
is	NULL
induced	NULL
by	NULL
a	NULL
constitutively	NULL
active	NULL
PKC	NULL
:	NULL
but	NULL
not	NULL
PKCa	NULL
nor	NULL
activated	NULL
ras	NULL
.	NULL
``	NULL

Moreover	NULL
,	NULL
the	NULL
IKK-related	NULL
kinase	NULL
named	NULL
NAK	NULL
(	NULL
NF-xB	NULL
activating	NULL
kinase	NULL
)	NULL
mediates	NULL
IKK	NULL
and	NULL
NF-xB	NULL
activation	NULL
in	NULL
response	NULL
to	NULL
growth	NULL
factors	NULL
that	NULL
stimulate	NULL
PKCs	NULL
activity	NULL
but	NULL
not	NULL
PKCa	NULL
or	NULL
0	NULL
.	NULL
``	NULL

''	NULL
Together	NULL
with	NULL
our	NULL
results	NULL
showing	NULL
a	NULL
similar	NULL
developmental	NULL
control	NULL
of	NULL
NF-kB	NULL
and	NULL
PKCs	NULL
,	NULL
these	NULL
findings	NULL
suggest	NULL
that	NULL
PKCs	NULL
may	NULL
control	NULL
NF-kB	NULL
in	NULL
thymocytes	NULL
.	NULL

Another	NULL
indication	NULL
that	NULL
PKCs	NULL
signal	NULL
for	NULL
NF-xB	NULL
comes	NULL
from	NULL
the	NULL
finding	NULL
that	NULL
TNF	NULL
receptor	NULL
signals	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
via	NULL
a	NULL
cascade	NULL
of	NULL
molecules	NULL
including	NULL
the	NULL
atypical	NULL
PKCS	NULL
and	NULL
PKC	NULL
.	NULL
``	NULL

This	NULL
result	NULL
is	NULL
particularly	NULL
interesting	NULL
in	NULL
the	NULL
connection	NULL
between	NULL
NF-kB	NULL
,	NULL
PKCs	NULL
and	NULL
TNF	NULL
receptor	NULL
signalling	NULL
for	NULL
death	NULL
.	NULL

More	NULL
specifically	NULL
the	NULL
isoform	NULL
PKCs	NULL
mediates	NULL
phorbol	NULL
ester	NULL
inhibition	NULL
of	NULL
TNFx-induced	NULL
apoptosis	NULL
in	NULL
U937	NULL
cells	NULL
.	NULL
``	NULL

Overexpression	NULL
of	NULL
PKC	NULL
isoform	NULL
&	NULL
but	NULL
not	NULL
5	NULL
in	NULL
human	NULL
interleukin-3-dependent	NULL
cells	NULL
suppresses	NULL
apoptosis	NULL
and	NULL
induces	NULL
Bel-2	NULL
expression	NULL
.	NULL
``	NULL

''	NULL
Hence	NULL
,	NULL
PKC	NULL
inhibitors	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
block	NULL
phosphorylation	NULL
of	NULL
Bcl-2	NULL
and	NULL
lead	NULL
to	NULL
apoptosis	NULL
whereas	NULL
activation	NULL
of	NULL
PKC	NULL
induced	NULL
phosphorylation	NULL
of	NULL
Bcl-2	NULL
and	NULL
abolished	NULL
the	NULL
apoptotic	NULL
process	NULL
.	NULL

``	NULL
``	NULL
*~	NULL
``	NULL
°	NULL
In	NULL
the	NULL
thymus	NULL
nearly	NULL
all	NULL
CD4	NULL
#	NULL
*	NULL
and	NULL
CD8+	NULL
SP	NULL
thymocytes	NULL
express	NULL
Bcl-2	NULL
whereas	NULL
the	NULL
majority	NULL
of	NULL
DP	NULL
thymocytes	NULL
do	NULL
not	NULL
.	NULL
``	NULL

''	NULL
The	NULL
constitutive	NULL
lack	NULL
of	NULL
PKCz	NULL
in	NULL
DP	NULL
thymocytes	NULL
detected	NULL
in	NULL
this	NULL
study	NULL
could	NULL
be	NULL
the	NULL
reason	NULL
for	NULL
the	NULL
developmentally	NULL
regulated	NULL
expression	NULL
of	NULL
Bcl-2	NULL
.	NULL

Recently	NULL
it	NULL
was	NULL
demonstrated	NULL
that	NULL
a	NULL
general	NULL
inhibitor	NULL
of	NULL
all	NULL
PKC	NULL
isoforms	NULL
prevented	NULL
peptide-specific	NULL
apoptosis	NULL
in	NULL
thymocytes	NULL
with	NULL
indirect	NULL
evidence	NULL
suggesting	NULL
the	NULL
responsible	NULL
isoform	NULL
might	NULL
be	NULL
PKC	NULL
0	NULL
.	NULL

``	NULL
°	NULL
In	NULL
contrast	NULL
a	NULL
PKC	NULL
inhibitor	NULL
facilitates	NULL
Fas-mediated	NULL
apoptosis	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
inhibits	NULL
T	NULL
cell-mediated	NULL
autoimmune	NULL
disease	NULL
.	NULL
``	NULL

''	NULL
The	NULL
controversy	NULL
in	NULL
these	NULL
studies	NULL
on	NULL
the	NULL
role	NULL
of	NULL
PKC	NULL
activity	NULL
in	NULL
apoptosis	NULL
suggests	NULL
that	NULL
different	NULL
PKC	NULL
isoforms	NULL
signal	NULL
for	NULL
different	NULL
events	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Overexpression	NULL
or	NULL
genetically	NULL
targeted	NULL
deletion	NULL
of	NULL
these	NULL
isoforms	NULL
in	NULL
the	NULL
thymus	NULL
would	NULL
elucidate	NULL
their	NULL
role	NULL
in	NULL
negative	NULL
selection	NULL
.	NULL

Furthermore	NULL
a	NULL
detailed	NULL
analysis	NULL
of	NULL
the	NULL
genomic	NULL
structure	NULL
of	NULL
PKCzs	NULL
would	NULL
elucidate	NULL
how	NULL
this	NULL
isoform	NULL
is	NULL
regulated	NULL
during	NULL
T	NULL
cell	NULL
development	NULL
.	NULL

Cell	NULL
Death	NULL
and	NULL
Differentiation	NULL
Materials	NULL
and	NULL
Methods	NULL
Mice	NULL
Mice	NULL
transgenic	NULL
for	NULL
the	NULL
KB5.C20	NULL
(	NULL
also	NULL
named	NULL
Des	NULL
)	NULL
TCR	NULL
have	NULL
been	NULL
described	NULL
elsewhere	NULL
.	NULL
``	NULL

''	NULL
Mice	NULL
,	NULL
between	NULL
4	NULL
and	NULL
8	NULL
weeks	NULL
old	NULL
,	NULL
were	NULL
of	NULL
the	NULL
H-2	NULL
«	NULL
haplotype	NULL
corresponding	NULL
to	NULL
the	NULL
background	NULL
of	NULL
positive	NULL
selection	NULL
.	NULL

Spleen	NULL
cells	NULL
from	NULL
B10.BR	NULL
(	NULL
H-2	NULL
``	NULL
,	NULL
control	NULL
)	NULL
and	NULL
C57BL/6	NULL
(	NULL
B6	NULL
,	NULL
H-2°	NULL
)	NULL
were	NULL
used	NULL
as	NULL
stimulating	NULL
cells	NULL
.	NULL

KB5.C20	NULL
TCR	NULL
is	NULL
specific	NULL
for	NULL
an	NULL
endogenous	NULL
peptide	NULL
present	NULL
in	NULL
B6	NULL
cells	NULL
in	NULL
association	NULL
with	NULL
H-2K®	NULL
.	NULL

Specific	NULL
peptide	NULL
(	NULL
pKB1	NULL
,	NULL
Guimezanes	NULL
et	NULL
a/	NULL
,	NULL
submitted	NULL
)	NULL
was	NULL
added	NULL
when	NULL
indicated	NULL
.	NULL

Mice	NULL
expressing	NULL
simultaneously	NULL
a	NULL
dominant-negative	NULL
ras	NULL
(	NULL
dnras	NULL
)	NULL
and	NULL
Mek-1	NULL
(	NULL
dMek	NULL
)	NULL
transgenes	NULL
under	NULL
the	NULL
p56	NULL
``	NULL
proximal	NULL
promoter	NULL
were	NULL
provided	NULL
by	NULL
RM	NULL
Perlmutter®	NULL
and	NULL
crossed	NULL
onto	NULL
B10.BR	NULL
mice	NULL
.	NULL

Mice	NULL
transgenic	NULL
for	NULL
luciferase	NULL
under	NULL
control	NULL
of	NULL
AP-1	NULL
binding	NULL
sites	NULL
(	NULL
AP-1	NULL
luc	NULL
)	NULL
were	NULL
made	NULL
as	NULL
described.©	NULL
``	NULL
The	NULL
NF-xB	NULL
luciferase	NULL
reporter	NULL
mice	NULL
(	NULL
NF-xB	NULL
luc	NULL
)	NULL
were	NULL
made	NULL
using	NULL
the	NULL
pBIIX	NULL
construct	NULL
with	NULL
two	NULL
copies	NULL
of	NULL
the	NULL
xB	NULL
sequence	NULL
from	NULL
the	NULL
Igx	NULL
intronic	NULL
enhancer.©	NULL
>	NULL
Triple	NULL
transgenic	NULL
mice	NULL
containing	NULL
the	NULL
transgenes	NULL
for	NULL
the	NULL
T	NULL
cell	NULL
receptor	NULL
,	NULL
the	NULL
dnras/dMek	NULL
and	NULL
the	NULL
reporter	NULL
molecules	NULL
(	NULL
AP-1	NULL
luc	NULL
or	NULL
NF-xB	NULL
luc	NULL
)	NULL
were	NULL
obtained	NULL
by	NULL
crossing	NULL
in	NULL
our	NULL
animal	NULL
facility	NULL
.	NULL

Mice	NULL
transgenic	NULL
for	NULL
the	NULL
TCR	NULL
recognizing	NULL
hen	NULL
egg	NULL
lysozyme	NULL
(	NULL
HEL	NULL
)	NULL
and	NULL
bred	NULL
onto	NULL
a	NULL
CBA/J	NULL
background	NULL
were	NULL
a	NULL
kind	NULL
gift	NULL
from	NULL
Mark	NULL
Davis	NULL
(	NULL
Stanford	NULL
University	NULL
School	NULL
of	NULL
Medicine	NULL
)	NULL
.©*	NULL
B10.BR	NULL
and	NULL
CBA	NULL
mice	NULL
were	NULL
bred	NULL
in	NULL
the	NULL
animal	NULL
facility	NULL
of	NULL
the	NULL
Centre	NULL
d'Immunologie	NULL
de	NULL
Marseille	NULL
Luminy	NULL
.	NULL

Thymocytes	NULL
and	NULL
in	NULL
vitro	NULL
stimulation	NULL
Single	NULL
cell	NULL
suspensions	NULL
of	NULL
thymocytes	NULL
were	NULL
obtained	NULL
by	NULL
gentle	NULL
disruption	NULL
of	NULL
an	NULL
intact	NULL
thymus	NULL
.	NULL

Preselection	NULL
DP	NULL
(	NULL
MHC	NULL
class	NULL
I	NULL
'	NULL
``	NULL
TCR	NULL
!	NULL
``	NULL

CD69	NULL
``	NULL
)	NULL
were	NULL
purified	NULL
by	NULL
negative	NULL
selection	NULL
using	NULL
MACS	NULL
(	NULL
Miltenyi	NULL
Biotec	NULL
,	NULL
Bergisch	NULL
Gladbach	NULL
,	NULL
Germany	NULL
)	NULL
as	NULL
described	NULL
Thymic	NULL
CD8+*	NULL
(	NULL
SP	NULL
)	NULL
and	NULL
peripheral	NULL
CD8+*	NULL
(	NULL
SPN	NULL
)	NULL
were	NULL
purified	NULL
by	NULL
negative	NULL
selection	NULL
using	NULL
rat	NULL
anti-CD4	NULL
supernatant	NULL
(	NULL
H129.19.6	NULL
)	NULL
.	NULL

All	NULL
mAb	NULL
were	NULL
as	NULL
previously	NULL
referenced	NULL
.	NULL
``	NULL

Thymic	NULL
populations	NULL
were	NULL
added	NULL
to	NULL
equivalent	NULL
numbers	NULL
of	NULL
irradiated	NULL
splenic	NULL
T	NULL
cell-depleted	NULL
antigen	NULL
presenting	NULL
cells	NULL
(	NULL
APCs	NULL
)	NULL
from	NULL
mice	NULL
of	NULL
the	NULL
H-2	NULL
``	NULL
or	NULL
H-2	NULL
``	NULL
haplotype	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
~	NULL
``	NULL
M	NULL
specific	NULL
peptide	NULL
,	NULL
where	NULL
specified	NULL
,	NULL
for	NULL
indicated	NULL
periods	NULL
oftime	NULL
.	NULL

Thymocytes	NULL
were	NULL
incubated	NULL
at	NULL
1	NULL
x	NULL
10°	NULL
cells	NULL
perwellin	NULL
the	NULL
presence	NULL
of	NULL
APCs	NULL
or	NULL
10	NULL
ng/m	NULL
!	NULL

phorbol-myristate	NULL
acetate	NULL
(	NULL
PMA	NULL
,	NULL
Sigma	NULL
,	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
,	NULL
USA	NULL
)	NULL
plus	NULL
250	NULL
ng/ml	NULL
ionomycin	NULL
(	NULL
Calbiochem	NULL
,	NULL
La	NULL
Jolla	NULL
,	NULL
CA	NULL
,	NULL
USA	NULL
)	NULL
.	NULL

Three-colour	NULL
flow	NULL
cytometry	NULL
was	NULL
performed	NULL
on	NULL
thymocytes	NULL
using	NULL
anti-CD8	NULL
APC	NULL
(	NULL
Pharmingen	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
,	NULL
USA	NULL
)	NULL
,	NULL
anti-CD69	NULL
antibody	NULL
coupled	NULL
to	NULL
FITC	NULL
(	NULL
prepared	NULL
in	NULL
the	NULL
laboratory	NULL
)	NULL
and	NULL
anti-CD4	NULL
coupled	NULL
to	NULL
phycoerythrin	NULL
(	NULL
Caltag	NULL
,	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
,	NULL
USA	NULL
)	NULL
.	NULL

Annexin	NULL
V-FITC	NULL
was	NULL
purchased	NULL
from	NULL
Euromedex	NULL
(	NULL
Souffelweyersheim	NULL
,	NULL
France	NULL
)	NULL
and	NULL
used	NULL
according	NULL
to	NULL
the	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

Nuclear	NULL
extract	NULL
preparation	NULL
and	NULL
electromobility	NULL
shift	NULL
assay	NULL
Nuclear	NULL
extracts	NULL
from	NULL
thymocytes	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
.	NULL

>	NULL
Briefly	NULL
5	NULL
to	NULL
10x	NULL
10°	NULL
thymocytes	NULL
were	NULL
washed	NULL
with	NULL
PBS	NULL
and	NULL
resuspended	NULL
in	NULL
lysis	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
HEPES	NULL
,	NULL
pH	NULL
7.9	NULL
,	NULL
10	NULL
mM	NULL
Tris	NULL
,	NULL
60	NULL
mM	NULL
KCI	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
0.5	NULL
%	NULL
Nonidet	NULL
P-40	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
,	NULL
1	NULL
mM	NULL
phenylmethylsulphonyl	NULL
fluoride	NULL
)	NULL
.	NULL

The	NULL
nuclei	NULL
were	NULL
pelleted	NULL
and	NULL
resuspended	NULL
in	NULL
50	NULL
ul	NULL
nuclear	NULL
resuspension	NULL
buffer	NULL
(	NULL
250	NULL
mM	NULL
Tris	NULL
,	NULL
pH	NULL
7.8	NULL
,	NULL
60	NULL
mM	NULL
KCI	NULL
,	NULL
1	NULL
mM	NULL
dithiothreitol	NULL
)	NULL
and	NULL
sonicated	NULL
briefly	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
cleared	NULL
by	NULL
centrifugation	NULL
,	NULL
protein	NULL
concentrations	NULL
in	NULL
the	NULL
extracts	NULL
were	NULL
determined	NULL
and	NULL
equivalent	NULL
amounts	NULL
of	NULL
extracts	NULL
were	NULL
used	NULL
for	NULL
in	NULL
vitro	NULL
binding	NULL
assays	NULL
.	NULL

Binding	NULL
assays	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
labelled	NULL
oligonucleotides	NULL
containing	NULL
the	NULL
AP-1	NULL
and	NULL
NF-xB	NULL
binding	NULL
sites	NULL
were	NULL
carried	NULL
out	NULL
as	NULL
described	NULL
.	NULL
``	NULL

Supershift	NULL
experiments	NULL
were	NULL
Lack	NULL
of	NULL
NF-kB	NULL
and	NULL
PKC	NULL
:	NULL
in	NULL
CD4*CD8*	NULL
thymocytes	NULL
AK	NULL
Simon	NULL
et	NULL
al	NULL
1261	NULL
performed	NULL
previously	NULL
showing	NULL
that	NULL
oligonucleotides	NULL
are	NULL
specific	NULL
for	NULL
5	NULL
.	NULL

Epinat	NULL
JC	NULL
and	NULL
Gilmore	NULL
TD	NULL
(	NULL
1999	NULL
)	NULL
Diverse	NULL
agents	NULL
act	NULL
at	NULL
multiple	NULL
levels	NULL
to	NULL
inhibit	NULL
their	NULL
targets	NULL
.	NULL

Oct-1	NULL
oligonucleotides	NULL
were	NULL
used	NULL
as	NULL
a	NULL
control	NULL
to	NULL
check	NULL
the	NULL
Rel/NF-kappaB	NULL
signal	NULL
transduction	NULL
pathway	NULL
.	NULL

Oncogene	NULL
18	NULL
:	NULL
6896-6909	NULL
whether	NULL
cell	NULL
extracts	NULL
contained	NULL
DNA	NULL
binding	NULL
activity	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

6.	NULL
geTOLEM	NULL
’	NULL
PaﬁkerPandCtamr-EFHDﬁ	NULL
affirm	NULL
?	NULL

?	NULL

?	NULL

rfémemlegtf	NULL
rial	NULL
;	NULL
“	NULL
32:3	NULL
R	NULL
.	NULL

-alpha	NULL
,	NULL
-epsilon	NULL
,	NULL
and	NULL
-zeta	NULL
in	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

270	NULL
:	NULL
Oct-1	NULL
probes	NULL
had	NULL
the	NULL
following	NULL
sequence	NULL
:	NULL
7	NULL
.	NULL

Barkett	NULL
M	NULL
and	NULL
Gilmore	NULL
TD	NULL
(	NULL
1999	NULL
)	NULL
Control	NULL
of	NULL
apoptosis	NULL
by	NULL
Re/NF-kappaB	NULL
5'CTCTTTGAAAATATGTGTAATATGTAAAACATTT	NULL
transcription	NULL
factors	NULL
.	NULL

Oncogene	NULL
18	NULL
:	NULL
6910-6924	NULL
AGCTGAGAAACTTTTATACACATTATACATTTTGT	NULL
5	NULL
.	NULL

8	NULL
.	NULL

Swan	NULL
KA	NULL
,	NULL
Alberola	NULL
IJ	NULL
,	NULL
Gross	NULL
JA	NULL
,	NULL
Appleby	NULL
M.W	NULL
’	NULL
.	NULL

Forlbush	NULL
KA	NULL
’	NULL
.	NULL

Thomas	NULL
JF	NULL
alnd	NULL
Perlmutter	NULL
RM	NULL
(	NULL
1995	NULL
)	NULL
Involvement	NULL
of	NULL
p21	NULL
ras	NULL
distinguishes	NULL
positive	NULL
and	NULL
negative	NULL
selection	NULL
in	NULL
thymocytes	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

14	NULL
:	NULL
276-285	NULL
Luciferase	NULL
activity	NULL
analysis	NULL
9	NULL
.	NULL

Alberola-lla	NULL
J	NULL
,	NULL
Hogquist	NULL
KA	NULL
,	NULL
Swan	NULL
KA	NULL
,	NULL
Bevan	NULL
MJ	NULL
and	NULL
Perimutter	NULL
RM	NULL
(	NULL
1996	NULL
)	NULL
Positive	NULL
and	NULL
negative	NULL
selection	NULL
invoke	NULL
distinct	NULL
signaling	NULL
pathways	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

2x	NULL
10°	NULL
thymocytes	NULL
were	NULL
cultured	NULL
for	NULL
indicated	NULL
periods	NULL
of	NULL
time	NULL
,	NULL
in	NULL
vitro	NULL
184	NULL
:	NULL
9-18	NULL
stimulated	NULL
,	NULL
washed	NULL
twice	NULL
in	NULL
PBS	NULL
and	NULL
lysed	NULL
in	NULL
lysis	NULL
buffer	NULL
(	NULL
Luciferase	NULL
10	NULL
.	NULL

Alberola-lla	NULL
J	NULL
,	NULL
Forbush	NULL
KA	NULL
,	NULL
Seger	NULL
R	NULL
,	NULL
Krebs	NULL
EG	NULL
and	NULL
Perlmutter	NULL
RM	NULL
(	NULL
1995	NULL
)	NULL
Assay	NULL
,	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
,	NULL
USA	NULL
)	NULL
for	NULL
30	NULL
min	NULL
at	NULL
room	NULL
temperature	NULL
.	NULL

Selective	NULL
requirement	NULL
for	NULL
MAP	NULL
kinase	NULL
activation	NULL
in	NULL
thymocyte	NULL
differentiation	NULL
.	NULL

The	NULL
lysate	NULL
was	NULL
spun	NULL
down	NULL
for	NULL
2	NULL
min	NULL
and	NULL
total	NULL
supernatant	NULL
was	NULL
Nature	NULL
373	NULL
:	NULL
620-623	NULL
analyzed	NULL
using	NULL
a	NULL
luciferase	NULL
reagent	NULL
(	NULL
Promega	NULL
)	NULL
and	NULL
measured	NULL
in	NULL
a	NULL
11	NULL
.	NULL

Rincon	NULL
M	NULL
,	NULL
Whitmarsh	NULL
A	NULL
,	NULL
Yang	NULL
DD	NULL
,	NULL
Weiss	NULL
L	NULL
,	NULL
Derijard	NULL
B	NULL
,	NULL
Jayaraj	NULL
P	NULL
,	NULL
Davis	NULL
RJ	NULL
and	NULL
luminometer	NULL
(	NULL
Lumat	NULL
LB9GP	NULL
,	NULL
EG	NULL
&	NULL
G	NULL
Berthold	NULL
)	NULL
for	NULL
10	NULL
s.	NULL
The	NULL
back-	NULL
Flavell	NULL
R	NULL
(	NULL
1998	NULL
)	NULL
The	NULL
JNK	NULL
pathway	NULL
regulates	NULL
the	NULL
in	NULL
vivo	NULL
deletion	NULL
of	NULL
CD4+CD8+	NULL
ground	NULL
(	NULL
syngeneic	NULL
APCs	NULL
or	NULL
absence	NULL
of	NULL
PMA/ionomycin	NULL
)	NULL
was	NULL
thymocytes	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

188	NULL
:	NULL
1817-1830	NULL
12	NULL
.	NULL

Sugawara	NULL
T	NULL
,	NULL
Moriguchi	NULL
T	NULL
,	NULL
Nishida	NULL
E	NULL
and	NULL
Takahama	NULL
Y	NULL
(	NULL
1998	NULL
)	NULL
Differential	NULL
roles	NULL
of	NULL
subtracted	NULL
from	NULL
measured	NULL
values	NULL
.	NULL

ERK	NULL
and	NULL
p38	NULL
MAP	NULL
kinase	NULL
pathways	NULL
in	NULL
positive	NULL
and	NULL
negative	NULL
selection	NULL
.	NULL

Immunity	NULL
9	NULL
:	NULL
565-574	NULL
13	NULL
.	NULL

Curnow	NULL
SJ	NULL
and	NULL
Schmitt-Verhulst	NULL
A-M	NULL
(	NULL
1994	NULL
)	NULL
The	NULL
balance	NULL
between	NULL
deletion	NULL
and	NULL
Western	NULL
blot	NULL
activation	NULL
of	NULL
CD4*CD8*	NULL
thymocytes	NULL
is	NULL
controlled	NULL
by	NULL
TcR-antigen	NULL
interaction	NULL
and	NULL
5	NULL
x	NULL
10°	NULL
DP	NULL
thymocytes	NULL
,	NULL
thymic	NULL
CD8*	NULL
(	NULL
SP	NULL
)	NULL
or	NULL
peripheral	NULL
T	NULL
cells	NULL
(	NULL
SPN	NULL
is	NULL
affected	NULL
by	NULL
CsA	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

24	NULL
:	NULL
2401-2409	NULL
in	NULL
Figure	NULL
4	NULL
or	NULL
S	NULL
in	NULL
Figure	NULL
5	NULL
)	NULL
were	NULL
washed	NULL
and	NULL
cell	NULL
extracts	NULL
were	NULL
14	NULL
.	NULL

Vasquez	NULL
NJ	NULL
,	NULL
Kaye	NULL
J	NULL
and	NULL
Hedrick	NULL
SM	NULL
(	NULL
1992	NULL
)	NULL
In	NULL
vivo	NULL
and	NULL
in	NULL
vitro	NULL
clonal	NULL
deletion	NULL
of	NULL
prepared	NULL
by	NULL
lysis	NULL
in	NULL
PBS	NULL
containing	NULL
2	NULL
%	NULL
SDS	NULL
.	NULL

DNA	NULL
was	NULL
eliminated	NULL
,	NULL
double-positive	NULL
thymocytes	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

175	NULL
:	NULL
1307-1316	NULL
|-and	NULL
proteins	NULL
lyophilized	NULL
,	NULL
reconstituted	NULL
in	NULL
SDS	NULL
sample	NULL
buffer	NULL
,	NULL
and	NULL
__	NULL
!	NULL

>	NULL
EfréeoigryaﬁﬁmfmLzzgicgséiﬁcﬂumm	NULL
?	NULL

f	NULL
:	NULL
g	NULL
'	NULL
_	NULL
”	NULL
fsg	NULL
‘	NULL
f	NULL
”	NULL
zgg	NULL
:	NULL
‘	NULL
°	NULL
'd	NULL
separated	NULL
by	NULL
SDS-PAGE	NULL
in	NULL
7	NULL
%	NULL
polyacrylamide	NULL
gel	NULL
.	NULL

Proteins	NULL
Were	NULL
=	NULL
35.	NULL
croin	NULL
g	NULL
,	NULL
geals	NULL
C	NULL
,	NULL
Wilkie	NULL
T	NULL
,	NULL
Forbush	NULL
K	NULL
,	NULL
Simon	NULL
M	NULL
and	NULL
Perlmutter	NULL
R	NULL
(	NULL
1990	NULL
)	NULL
transferred	NULL
F0	NULL
PVDF-membranes	NULL
Iand	NULL
,	NULL
immunoblots	NULL
performed	NULL
.	NULL

Dissection	NULL
of	NULL
thymocyte	NULL
signaling	NULL
pathways	NULL
by	NULL
in	NULL
vivo	NULL
expression	NULL
of	NULL
pertussis	NULL
Antisera	NULL
against	NULL
PKC	NULL
a	NULL
,	NULL
&	NULL
,	NULL
{	NULL
,	NULL
6	NULL
(	NULL
a	NULL
kind	NULL
gift	NULL
from	NULL
Peter	NULL
Parker	NULL
)	NULL
were	NULL
toxin	NULL
ADP	NULL
-ribosyltransferase	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

9	NULL
:	NULL
3821-3829	NULL
diluted	NULL
1:500	NULL
for	NULL
&	NULL
and	NULL
8	NULL
;	NULL
1:100	NULL
for	NULL
«	NULL
and	NULL
B	NULL
.	NULL

Specific	NULL
peptide	NULL
from	NULL
17	NULL
.	NULL

Cantrell	NULL
D	NULL
(	NULL
1996	NULL
)	NULL
T	NULL
cell	NULL
antigen	NULL
receptor	NULL
signal	NULL
transduction	NULL
pathways	NULL
.	NULL

Annu	NULL
.	NULL

PKCs	NULL
was	NULL
added	NULL
just	NULL
before	NULL
and	NULL
at	NULL
the	NULL
same	NULL
concentration	NULL
as	NULL
the	NULL
Rev	NULL
.	NULL

Immunol	NULL
.	NULL

14	NULL
:	NULL
259-274	NULL
antiserum	NULL
.	NULL

Rabbit	NULL
polyclonal	NULL
IgG	NULL
against	NULL
PKCs	NULL
and	NULL
«	NULL
for	NULL
a	NULL
second	NULL
18	NULL
.	NULL

Chen	NULL
D	NULL
and	NULL
Rothenberg	NULL
E	NULL
(	NULL
1993	NULL
)	NULL
Molecular	NULL
basis	NULL
for	NULL
developmental	NULL
changes	NULL
in	NULL
series	NULL
of	NULL
blots	NULL
were	NULL
purchased	NULL
from	NULL
Santa	NULL
Cruz	NULL
Biotechnology	NULL
(	NULL
Santa	NULL
interleukin-2	NULL
gene	NULL
inducibility	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

13	NULL
:	NULL
228-237	NULL
Cruz	NULL
,	NULL
CA	NULL
,	NULL
USA	NULL
)	NULL
.	NULL

These	NULL
antisera	NULL
were	NULL
used	NULL
at	NULL
1:5000	NULL
(	NULL
0.02	NULL
ug	NULL
/ml	NULL
)	NULL
19	NULL
.	NULL

Rincon	NULL
M	NULL
and	NULL
Flavell	NULL
RA	NULL
(	NULL
1996	NULL
)	NULL
Regulation	NULL
of	NULL
AP-1	NULL
and	NULL
NF-AT	NULL
transcription	NULL
and	NULL
the	NULL
blots	NULL
revealed	NULL
using	NULL
a	NULL
chemiluminescence-dependent	NULL
method	NULL
factors	NULL
during	NULL
thymic	NULL
selection	NULL
of	NULL
T	NULL
cells	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16	NULL
:	NULL
1074-1084	NULL
(	NULL
ECL	NULL
,	NULL
Amersham	NULL
)	NULL
.	NULL

20	NULL
.	NULL

Berry	NULL
N	NULL
,	NULL
Ase	NULL
K	NULL
,	NULL
Kikkawa	NULL
U	NULL
,	NULL
Kishimoto	NULL
A	NULL
and	NULL
Nishizuka	NULL
Y	NULL
(	NULL
1989	NULL
)	NULL
Human	NULL
T	NULL
cell	NULL
activation	NULL
by	NULL
phorbol	NULL
esters	NULL
and	NULL
diacylglycerol	NULL
analogues	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

143	NULL
:	NULL
1407-1413	NULL
21	NULL
.	NULL

Strulovici	NULL
B	NULL
,	NULL
Daniel-Issakani	NULL
S	NULL
,	NULL
Baxter	NULL
G	NULL
,	NULL
Knopf	NULL
J	NULL
,	NULL
Sultzman	NULL
L	NULL
,	NULL
Cherwinski	NULL
H	NULL
,	NULL
Nestor	NULL
J	NULL
,	NULL
Webb	NULL
D	NULL
and	NULL
Ransom	NULL
J	NULL
(	NULL
1991	NULL
)	NULL
Distinct	NULL
mechanisms	NULL
of	NULL
regulation	NULL
of	NULL
Acknowledgements	NULL
protein	NULL
kinase	NULL
C	NULL
epsilon	NULL
by	NULL
hormones	NULL
and	NULL
phorbol	NULL
diesters	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

266	NULL
:	NULL
168-173	NULL
We	NULL
thank	NULL
José	NULL
Alberola-lla	NULL
and	NULL
Roger	NULL
Perlmutter	NULL
for	NULL
providing	NULL
the	NULL
dnras/	NULL
22	NULL
.	NULL

OhakaY	NULL
,	NULL
Kuwata	NULL
T	NULL
,	NULL
Asada	NULL
A	NULL
,	NULL
Zhao	NULL
Y	NULL
,	NULL
Mukai	NULL
M	NULL
and	NULL
Iwata	NULL
M	NULL
(	NULL
1997	NULL
)	NULL
Regulation	NULL
of	NULL
dMek	NULL
mice	NULL
,	NULL
Peter	NULL
Parker	NULL
for	NULL
the	NULL
PKC	NULL
antisera	NULL
,	NULL
Gilles	NULL
Warcollier	NULL
and	NULL
thymocyte	NULL
lineage	NULL
commitment	NULL
by	NULL
the	NULL
level	NULL
of	NULL
classical	NULL
protein	NULL
kinase	NULL
C	NULL
activity	NULL
.	NULL

Michel	NULL
Pontier	NULL
for	NULL
animal	NULL
care	NULL
and	NULL
Sylvie	NULL
Guerder	NULL
for	NULL
providing	NULL
data	NULL
on	NULL
J.	NULL
Immunol	NULL
.	NULL

158	NULL
:	NULL
5707-5716	NULL
peripheral	NULL
T	NULL
cells	NULL
,	NULL
performing	NULL
Oct-1	NULL
gelshifts	NULL
and	NULL
breeding	NULL
the	NULL
luciferase	NULL
23	NULL
.	NULL

Asada	NULL
A	NULL
,	NULL
Zhao	NULL
Y	NULL
,	NULL
Kondo	NULL
S	NULL
and	NULL
Iwata	NULL
M	NULL
(	NULL
1998	NULL
)	NULL
Induction	NULL
of	NULL
thymocyte	NULL
apoptosis	NULL
mice	NULL
.	NULL

AK	NULL
Simon	NULL
was	NULL
a	NULL
recipient	NULL
of	NULL
a	NULL
postdoctoral	NULL
fellowship	NULL
from	NULL
the	NULL
by	NULL
Ca®+*-independent	NULL
Protein	NULL
Kinase	NULL
C	NULL
(	NULL
nPKC	NULL
)	NULL
activation	NULL
and	NULL
its	NULL
regulation	NULL
by	NULL
Deutsche	NULL
Forschungsgemeinschaft	NULL
.	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
calcineurin	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273	NULL
:	NULL
28392-28398	NULL
L	NULL
institutional	NULL
grants	NULL
from	NULL
Institut	NULL
National	NULL
de	NULL
la	NULL
Santé	NULL
et	NULL
de	NULL
la	NULL
Recherche	NULL
_	NULL
24-	NULL
Goodnight	NULL
J	NULL
,	NULL
Mischak	NULL
H	NULL
and	NULL
Mushinski	NULL
JF	NULL
(	NULL
1994	NULL
)	NULL
Selective	NULL
involvement	NULL
of	NULL
médicale	NULL
(	NULL
INSERM	NULL
)	NULL
and	NULL
Centre	NULL
National	NULL
de	NULL
la	NULL
Recherche	NULL
Scientifique	NULL
grscgelqgénase	NULL
C	NULL
isozymes	NULL
in	NULL
neoplastic	NULL
transformation	NULL
.	NULL

Adv	NULL
.	NULL

Cancer	NULL
Res	NULL
.	NULL

64	NULL
:	NULL
(	NULL
CNRS	NULL
)	NULL
and	NULL
py	NULL
grams-from	NULL
Association	NULL
pour	NULL
la	NULL
Recherche	NULL
sur	NULL
le	NULL
Cancer	NULL
25	NULL
.	NULL

Dudley	NULL
E	NULL
,	NULL
Homung	NULL
F	NULL
,	NULL
Zheng	NULL
L	NULL
,	NULL
Scherer	NULL
D	NULL
,	NULL
Ballard	NULL
D	NULL
and	NULL
Lenardo	NULL
M	NULL
(	NULL
1999	NULL
)	NULL
NF-	NULL
(	NULL
Ami	NULL
the	NULL
Ligue	NULL
NatlonaIeAComre	NULL
le	NULL
Cancer	NULL
(	NULL
LNCC	NULL
)	NULL
and	NULL
the	NULL
LNCC-	NULL
kappaB	NULL
regulates	NULL
Fas/APO-1/CD95-	NULL
and	NULL
TCR-mediated	NULL
apoptosis	NULL
of	NULL
T	NULL
Comité	NULL
des	NULL
Bouches	NULL
du	NULL
Rhone	NULL
.	NULL

lymphocytes	NULL
.	NULL

Eur	NULL
J.	NULL
Immunol	NULL
.	NULL

29	NULL
:	NULL
878-886	NULL
26	NULL
.	NULL

Wang	NULL
W	NULL
,	NULL
Wykrzykowska	NULL
J	NULL
,	NULL
Johnson	NULL
T	NULL
,	NULL
Sen	NULL
Rand	NULL
Sen	NULL
J	NULL
(	NULL
1999	NULL
)	NULL
A	NULL
NF-kappa	NULL
B/c-myc-dependent	NULL
survival	NULL
pathway	NULL
is	NULL
targeted	NULL
by	NULL
corticosteroids	NULL
in	NULL
immature	NULL
thymocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

162	NULL
:	NULL
314-322	NULL
References	NULL
27	NULL
.	NULL

Hettmann	NULL
T	NULL
,	NULL
Didonato	NULL
J	NULL
,	NULL
Karin	NULL
M	NULL
and	NULL
Leiden	NULL
JM	NULL
(	NULL
1999	NULL
)	NULL
An	NULL
essential	NULL
role	NULL
for	NULL
,	NULL
20.	NULL
,	NULL
al	NULL
Nuclear	NULL
Factor	NULL
xB	NULL
in	NULL
promoting	NULL
double	NULL
positive	NULL
thymocyte	NULL
apoptosis	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

1	NULL
.	NULL

Surh	NULL
CD	NULL
and	NULL
Sprent	NULL
J	NULL
(	NULL
1994	NULL
)	NULL
T-cell	NULL
apoptosis	NULL
detected	NULL
in	NULL
situduring	NULL
positive	NULL
and	NULL
Med	NULL
.	NULL

189	NULL
:	NULL
145-157	NULL
negative	NULL
selection	NULL
in	NULL
the	NULL
thymus	NULL
.	NULL

Nature	NULL
372	NULL
:	NULL
100-103	NULL
28	NULL
.	NULL

Legendre	NULL
V.	NULL
CGuimezanes	NULL
A.	NULL
Buferne	NULL
M.	NULL
Barad	NULL
M.	NULL
Schmitt-Verhulst	NULL
AM	NULL
an	NULL
2.	NULL
yﬂﬁifﬁgrigaisfszgtgd	NULL
ggasTrlnzsuflﬁgﬂ	NULL
Sziggalégéolved	NULL
in	NULL
thymocyte	NULL
°	NULL
553233621	NULL
9g	NULL
)	NULL
9Cf	NULL
)	NULL
uAnt	NULL
?	NULL

g	NULL
:	NULL
:1nﬁrsldu	NULL
‘	NULL
cet	NULL
;	NULL
J	NULL
Ems-063	NULL
goﬁn-myoiilation	NULL
die	NULL
:	NULL
rslot	NULL
requlircei	NULL
3	NULL
.	NULL

Simon	NULL
AK	NULL
,	NULL
Auphan	NULL
N	NULL
land	NULL
Schmitt—Verhulst	NULL
A-M	NULL
(	NULL
1996	NULL
)	NULL
Development	NULL
control	NULL
of	NULL
gggiﬁigx	NULL
ﬁgfmfngﬁ	NULL
’	NULL
tafgzc	NULL
E	NULL
$	NULL
9132	NULL
“	NULL
necessary	NULL
in	NULL
response	NULL
to	NULL
ant	NULL
antigen-induced	NULL
thymic	NULL
transcription	NULL
factors	NULL
.	NULL

Int	NULL
.	NULL

Immunol	NULL
.	NULL

8	NULL
:	NULL
1421-1428	NULL
29	NULL
.	NULL

Wong	NULL
B	NULL
,	NULL
Arron	NULL
J	NULL
and	NULL
Choi	NULL
Y	NULL
(	NULL
1997	NULL
)	NULL
T	NULL
cell	NULL
receptor	NULL
signals	NULL
enhance	NULL
susceptibility	NULL
4	NULL
.	NULL

Karin	NULL
M	NULL
(	NULL
1999	NULL
)	NULL
How	NULL
NF-kappaB	NULL
is	NULL
activated	NULL
:	NULL
the	NULL
role	NULL
of	NULL
the	NULL
IkappaB	NULL
kinase	NULL
(	NULL
IKK	NULL
)	NULL
complex	NULL
.	NULL

Oncogene	NULL
18	NULL
:	NULL
6867-6874	NULL
to	NULL
Fas-mediated	NULL
apoptosis	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

186	NULL
:	NULL
1939-1944	NULL
Cell	NULL
Death	NULL
and	NULL
Differentiation	NULL
Lack	NULL
of	NULL
NF-xB	NULL
and	NULL
PKC	NULL
:	NULL
in	NULL
CD4*CD8*	NULL
thymocytes	NULL
AK	NULL
Simon	NULL
et	NULL
al	NULL
1262	NULL
30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

41	NULL
.	NULL

42	NULL
.	NULL

43	NULL
.	NULL

44	NULL
.	NULL

45	NULL
.	NULL

46	NULL
.	NULL

47	NULL
.	NULL

48	NULL
.	NULL

Hsu	NULL
H	NULL
,	NULL
Shu	NULL
H	NULL
,	NULL
Pan	NULL
M	NULL
and	NULL
Goeddel	NULL
DV	NULL
(	NULL
1996	NULL
)	NULL
TRADD-TRAF2	NULL
and	NULL
TRADD-FADD	NULL
interactions	NULL
define	NULL
two	NULL
distinct	NULL
TNF	NULL
receptor	NULL
signal	NULL
transduction	NULL
pathways	NULL
.	NULL

Cell	NULL
84	NULL
:	NULL
299-308	NULL
Liu	NULL
Z	NULL
,	NULL
Hsu	NULL
H	NULL
,	NULL
Goeddel	NULL
DV	NULL
and	NULL
Karin	NULL
M	NULL
(	NULL
1996	NULL
)	NULL
Dissection	NULL
of	NULL
TNF	NULL
receptor	NULL
1	NULL
effector	NULL
functions	NULL
:	NULL
JNK	NULL
activation	NULL
is	NULL
not	NULL
linked	NULL
to	NULL
apoptosis	NULL
while	NULL
NF-kB	NULL
activation	NULL
prevents	NULL
cell	NULL
death	NULL
.	NULL

Cell	NULL
87	NULL
:	NULL
565-576	NULL
Baeuerle	NULL
PA	NULL
and	NULL
Baltimore	NULL
D	NULL
(	NULL
1996	NULL
)	NULL
NF-xB	NULL
:	NULL
ten	NULL
years	NULL
after	NULL
.	NULL

Cell	NULL
87	NULL
:	NULL
13-20	NULL
Wu	NULL
M	NULL
,	NULL
Lee	NULL
M	NULL
,	NULL
Bellas	NULL
RE	NULL
,	NULL
Schauer	NULL
SL	NULL
,	NULL
Arsura	NULL
M	NULL
,	NULL
Katz	NULL
D	NULL
,	NULL
FitzGerald	NULL
MJ	NULL
,	NULL
Rothstein	NULL
TL	NULL
,	NULL
Sherr	NULL
DM	NULL
and	NULL
Sonenshein	NULL
GE	NULL
(	NULL
1996	NULL
)	NULL
Inhibition	NULL
of	NULL
NF-kappa	NULL
B/rel	NULL
induces	NULL
apoptosis	NULL
of	NULL
murine	NULL
B	NULL
cells	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

15	NULL
:	NULL
4682-4690	NULL
Nagata	NULL
S	NULL
(	NULL
1997	NULL
)	NULL
Apoptosis	NULL
by	NULL
death	NULL
factor	NULL
.	NULL

Cell	NULL
88	NULL
:	NULL
355-365	NULL
Van	NULL
Antwerp	NULL
D	NULL
,	NULL
Martin	NULL
S	NULL
,	NULL
Verma	NULL
I	NULL
and	NULL
Green	NULL
D	NULL
(	NULL
1998	NULL
)	NULL
Inhibition	NULL
of	NULL
TNF-induced	NULL
apoptosis	NULL
by	NULL
NF-xB	NULL
.	NULL

Trends	NULL
Cell	NULL
.	NULL

Biol	NULL
.	NULL

8	NULL
:	NULL
107-110	NULL
Lee	NULL
HH	NULL
,	NULL
Dadgostar	NULL
H	NULL
,	NULL
Cheng	NULL
Q	NULL
,	NULL
Shu	NULL
J	NULL
and	NULL
Cheng	NULL
G	NULL
(	NULL
1999	NULL
)	NULL
NF-kappaB-mediated	NULL
up-regulation	NULL
of	NULL
Bcl-x	NULL
and	NULL
Bfl-1/A1	NULL
is	NULL
required	NULL
for	NULL
CD40	NULL
survival	NULL
signaling	NULL
in	NULL
B	NULL
lymphocytes	NULL
.	NULL

Proc	NULL
.	NULL

Natl	NULL
.	NULL

Acad	NULL
.	NULL

Sci	NULL
.	NULL

USA	NULL
96	NULL
:	NULL
9136-9141	NULL
Chiarle	NULL
R	NULL
,	NULL
Podda	NULL
A	NULL
,	NULL
Prolla	NULL
G	NULL
,	NULL
Podack	NULL
ER	NULL
,	NULL
Thorbecke	NULL
GJ	NULL
and	NULL
Inghirami	NULL
G	NULL
(	NULL
1999	NULL
)	NULL
CD30	NULL
overexpression	NULL
enhances	NULL
negative	NULL
selection	NULL
in	NULL
the	NULL
thymus	NULL
and	NULL
mediates	NULL
programmed	NULL
cell	NULL
death	NULL
via	NULL
a	NULL
Bcl-2-sensitive	NULL
pathway	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

163	NULL
:	NULL
194-205	NULL
Zhong	NULL
H	NULL
,	NULL
Su	NULL
Yang	NULL
H	NULL
,	NULL
Erdjument-Bromage	NULL
H	NULL
,	NULL
Tempst	NULL
P	NULL
and	NULL
Ghosh	NULL
S	NULL
(	NULL
1997	NULL
)	NULL
The	NULL
transcriptional	NULL
activity	NULL
of	NULL
NF-xB	NULL
is	NULL
regulated	NULL
by	NULL
the	NULL
IxB-associated	NULL
PKAc	NULL
subunit	NULL
through	NULL
a	NULL
cyclic	NULL
AMP-independent	NULL
mechanism	NULL
.	NULL

Cell	NULL
89	NULL
:	NULL
413-424	NULL
Porritt	NULL
HE	NULL
,	NULL
Anderson	NULL
KL	NULL
,	NULL
Suniara	NULL
RK	NULL
,	NULL
Jenkinson	NULL
EJ	NULL
and	NULL
Owen	NULL
JT	NULL
(	NULL
1998	NULL
)	NULL
Cellular	NULL
interactions	NULL
in	NULL
the	NULL
thymus	NULL
regulate	NULL
the	NULL
protein	NULL
kinase	NULL
C	NULL
signaling	NULL
pathway	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

28	NULL
:	NULL
1197-1203	NULL
Karin	NULL
M	NULL
,	NULL
Liu	NULL
Z	NULL
and	NULL
Zandi	NULL
E	NULL
(	NULL
1997	NULL
)	NULL
AP-1	NULL
function	NULL
and	NULL
regulation	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

9	NULL
:	NULL
240-246	NULL
Minden	NULL
A	NULL
,	NULL
Lin	NULL
A	NULL
,	NULL
McMahon	NULL
M	NULL
,	NULL
Lange-Carter	NULL
C	NULL
,	NULL
Dérijard	NULL
B	NULL
,	NULL
Davis	NULL
RJ	NULL
,	NULL
Johnson	NULL
GL	NULL
and	NULL
Karin	NULL
M	NULL
(	NULL
1994	NULL
)	NULL
Differential	NULL
actvation	NULL
of	NULL
ERK	NULL
and	NULL
JNK	NULL
Mitogen-activated	NULL
Protein	NULL
Kinases	NULL
by	NULL
Raf-1	NULL
and	NULL
MEKK	NULL
.	NULL

Science	NULL
266	NULL
:	NULL
1719-1721	NULL
Williams	NULL
DH	NULL
,	NULL
Woodrow	NULL
M	NULL
,	NULL
Cantrell	NULL
DA	NULL
and	NULL
Murray	NULL
EJ	NULL
(	NULL
1995	NULL
)	NULL
Protein	NULL
Kinase	NULL
C	NULL
is	NULL
nota	NULL
downstream	NULL
effector	NULL
of	NULL
p21ras	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

25	NULL
:	NULL
42	NULL
47	NULL
Downward	NULL
J	NULL
,	NULL
Graves	NULL
JD	NULL
,	NULL
Warne	NULL
PH	NULL
,	NULL
Rayter	NULL
S	NULL
and	NULL
Cantrell	NULL
DA	NULL
(	NULL
1990	NULL
)	NULL
Stimulation	NULL
of	NULL
p21ras	NULL
upon	NULL
T	NULL
cell	NULL
activation	NULL
.	NULL

Nature	NULL
346	NULL
:	NULL
719-723	NULL
Mischak	NULL
H	NULL
,	NULL
Kolch	NULL
W	NULL
,	NULL
Goodnight	NULL
J	NULL
,	NULL
Davidson	NULL
WF	NULL
,	NULL
Rapp	NULL
U	NULL
,	NULL
Rose-John	NULL
S	NULL
and	NULL
MushinskiJF	NULL
(	NULL
1991	NULL
)	NULL
Expression	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
genes	NULL
in	NULL
hemopoeitic	NULL
cells	NULL
is	NULL
cell-type	NULL
and	NULL
B-cell-differentiation	NULL
stage	NULL
specific	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

147	NULL
:	NULL
3981-3987	NULL
Mischak	NULL
H	NULL
,	NULL
Goodnight	NULL
J	NULL
,	NULL
Kolch	NULL
W	NULL
,	NULL
Martiny-Baron	NULL
G	NULL
,	NULL
Schaechtle	NULL
C	NULL
,	NULL
Kazanietz	NULL
MG	NULL
,	NULL
Blumberg	NULL
PM	NULL
,	NULL
Pierce	NULL
JH	NULL
and	NULL
Mushinski	NULL
JF	NULL
(	NULL
1993	NULL
)	NULL
Overexpression	NULL
of	NULL
protein	NULL
kinase	NULL
C-delta	NULL
and	NULL
-epsilon	NULL
in	NULL
NIH3T3	NULL
cells	NULL
induces	NULL
opposite	NULL
effects	NULL
on	NULL
growth	NULL
,	NULL
morphology	NULL
,	NULL
anchorage	NULL
dependence	NULL
,	NULL
and	NULL
tumorigenicity	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
:	NULL
6090-6096	NULL
Baier	NULL
G	NULL
,	NULL
Telford	NULL
D	NULL
,	NULL
Giampa	NULL
L	NULL
,	NULL
Coggeshall	NULL
KM	NULL
,	NULL
Baier-Biterlich	NULL
G	NULL
,	NULL
Isakov	NULL
N	NULL
and	NULL
Altman	NULL
A	NULL
(	NULL
1993	NULL
)	NULL
Molecular	NULL
cloning	NULL
and	NULL
characterization	NULL
of	NULL
PKC	NULL
theta	NULL
,	NULL
a	NULL
novel	NULL
member	NULL
of	NULL
the	NULL
protein	NULL
kinase	NULL
C	NULL
(	NULL
PKC	NULL
)	NULL
gene	NULL
family	NULL
expressed	NULL
predominantly	NULL
in	NULL
hemapoietic	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

268	NULL
:	NULL
4997-5004	NULL
Monks	NULL
CR	NULL
,	NULL
KupferH	NULL
,	NULL
Tamirl	NULL
,	NULL
Barlow	NULL
A	NULL
and	NULL
Kupfer	NULL
A	NULL
(	NULL
1997	NULL
)	NULL
Selective	NULL
modulation	NULL
of	NULL
protein	NULL
kinase	NULL
C-theta	NULL
during	NULL
T-cell	NULL
activation	NULL
.	NULL

Nature	NULL
385	NULL
:	NULL
83-86	NULL
Villalba	NULL
M	NULL
,	NULL
Kasibhatla	NULL
S	NULL
,	NULL
Genestier	NULL
L	NULL
,	NULL
Mahboubi	NULL
A	NULL
,	NULL
Green	NULL
DR	NULL
and	NULL
Altman	NULL
A	NULL
(	NULL
1999	NULL
)	NULL
Protein	NULL
kinase	NULL
C	NULL
theta	NULL
cooperates	NULL
with	NULL
calcineurin	NULL
to	NULL
induce	NULL
Fas	NULL
ligand	NULL
expression	NULL
during	NULL
activation-induced	NULL
T	NULL
cell	NULL
death	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

163	NULL
:	NULL
5813-5819	NULL
Cell	NULL
Death	NULL
and	NULL
Differentiation	NULL
49	NULL
.	NULL

50	NULL
.	NULL

51	NULL
.	NULL

52	NULL
.	NULL

53	NULL
.	NULL

54	NULL
.	NULL

55	NULL
.	NULL

56	NULL
.	NULL

58	NULL
.	NULL

59	NULL
.	NULL

60	NULL
.	NULL

61	NULL
.	NULL

62	NULL
.	NULL

63	NULL
.	NULL

64	NULL
.	NULL

Baier-Bitterlich	NULL
G	NULL
,	NULL
Uberall	NULL
F	NULL
,	NULL
Bauer	NULL
B	NULL
,	NULL
Fresser	NULL
F	NULL
,	NULL
Wachter	NULL
H	NULL
,	NULL
Grunicke	NULL
H	NULL
,	NULL
Utermann	NULL
G	NULL
,	NULL
Altman	NULL
A	NULL
and	NULL
Baier	NULL
G	NULL
(	NULL
1996	NULL
)	NULL
Protein	NULL
kinase	NULL
C-theta	NULL
isoenzyme	NULL
selective	NULL
stimulation	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
complex	NULL
AP-1	NULL
in	NULL
T	NULL
lymphocytes	NULL
.	NULL

Mol	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

16	NULL
:	NULL
1842-1850	NULL
Sun	NULL
Z	NULL
,	NULL
Arendt	NULL
CW	NULL
,	NULL
Ellmeier	NULL
W	NULL
,	NULL
Schaeffer	NULL
EM	NULL
,	NULL
Sunshine	NULL
MJ	NULL
,	NULL
Gandhi	NULL
L	NULL
,	NULL
Annes	NULL
J	NULL
,	NULL
Petrzilka	NULL
D	NULL
,	NULL
Kupfer	NULL
A	NULL
,	NULL
Schwartzberg	NULL
PL	NULL
and	NULL
Littman	NULL
DR	NULL
(	NULL
2000	NULL
)	NULL
PKC-theta	NULL
is	NULL
required	NULL
for	NULL
TCR-induced	NULL
NF-kappaB	NULL
activation	NULL
in	NULL
mature	NULL
but	NULL
not	NULL
immature	NULL
T	NULL
lymphocytes	NULL
.	NULL

Nature	NULL
404	NULL
:	NULL
402-407	NULL
Tojima	NULL
Y	NULL
,	NULL
Fujimoto	NULL
A	NULL
,	NULL
Delthase	NULL
M	NULL
,	NULL
Chen	NULL
Y	NULL
,	NULL
Hatakeyama	NULL
S	NULL
,	NULL
NakayamaK	NULL
,	NULL
Kaneko	NULL
Y	NULL
,	NULL
Nimura	NULL
Y	NULL
,	NULL
Motoyama	NULL
N	NULL
,	NULL
Ikeda	NULL
K	NULL
,	NULL
Karin	NULL
M	NULL
and	NULL
Nakanishi	NULL
M	NULL
(	NULL
2000	NULL
)	NULL
NAK	NULL
is	NULL
an	NULL
IkappaB	NULL
kinase-activating	NULL
kinase	NULL
.	NULL

Nature	NULL
404	NULL
:	NULL
778-782	NULL
Sanz	NULL
L	NULL
,	NULL
Sanchez	NULL
P	NULL
,	NULL
Lallena	NULL
M-J	NULL
,	NULL
Diaz-Meco	NULL
MT	NULL
and	NULL
Moscat	NULL
J	NULL
(	NULL
1999	NULL
)	NULL
The	NULL
interaction	NULL
of	NULL
p62	NULL
with	NULL
RIP	NULL
links	NULL
the	NULL
atypical	NULL
PKCs	NULL
to	NULL
NF-kappaB	NULL
activation	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

18	NULL
:	NULL
3044-3053	NULL
Mayne	NULL
GC	NULL
and	NULL
Murray	NULL
AW	NULL
(	NULL
1998	NULL
)	NULL
Evidence	NULL
that	NULL
protein	NULL
kinase	NULL
Cs	NULL
mediates	NULL
phorbol	NULL
ester	NULL
inhibition	NULL
of	NULL
Calphostin	NULL
C-	NULL
and	NULL
Tumor	NULL
Necrosis	NULL
Factor-	NULL
«	NULL
-induced	NULL
apoptosis	NULL
in	NULL
U937	NULL
histiocyte	NULL
lymphoma	NULL
cells	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

37	NULL
:	NULL
24115-24121	NULL
Gubina	NULL
E	NULL
,	NULL
Rinaudo	NULL
M	NULL
,	NULL
Szallasi	NULL
Z	NULL
,	NULL
Blumberg	NULL
P	NULL
and	NULL
Mufson	NULL
R	NULL
(	NULL
1998	NULL
)	NULL
Overexpression	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
isoform	NULL
&	NULL
but	NULL
not	NULL
3	NULL
in	NULL
human	NULL
interleukin-3-dependent	NULL
cells	NULL
suppresses	NULL
apoptosis	NULL
and	NULL
induces	NULL
bel-2	NULL
expression	NULL
.	NULL

Blood	NULL
91	NULL
:	NULL
823-829	NULL
Emoto	NULL
Y	NULL
,	NULL
Kisaki	NULL
H	NULL
,	NULL
Manome	NULL
Y	NULL
,	NULL
Kharbanda	NULL
S	NULL
and	NULL
Kufe	NULL
D	NULL
(	NULL
1996	NULL
)	NULL
Activation	NULL
of	NULL
protein	NULL
kinase	NULL
Cdelta	NULL
in	NULL
human	NULL
myeloid	NULL
leukemia	NULL
cells	NULL
treated	NULL
with	NULL
1-beta-D-arabinofuranosylcytosine	NULL
.	NULL

Blood	NULL
87	NULL
:	NULL
1990-1996	NULL
Ruvolo	NULL
PP	NULL
,	NULL
Deng	NULL
X	NULL
,	NULL
Carr	NULL
BK	NULL
and	NULL
May	NULL
WS	NULL
(	NULL
1998	NULL
)	NULL
A	NULL
functional	NULL
role	NULL
for	NULL
mitochondrial	NULL
protein	NULL
kinase	NULL
Calpha	NULL
in	NULL
Bcl2	NULL
phosphorylation	NULL
and	NULL
suppression	NULL
of	NULL
apoptosis	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

273	NULL
:	NULL
25436	NULL
-	NULL
25442	NULL
.	NULL

Gratiot-Deans	NULL
J	NULL
,	NULL
Ding	NULL
L	NULL
,	NULL
Turka	NULL
LA	NULL
and	NULL
Nunez	NULL
G	NULL
(	NULL
1993	NULL
)	NULL
bel-2	NULL
proto-oncogene	NULL
expression	NULL
during	NULL
human	NULL
T	NULL
cell	NULL
development	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

151	NULL
:	NULL
83-91	NULL
Linette	NULL
GP	NULL
,	NULL
Grusby	NULL
MJ	NULL
,	NULL
Hedrick	NULL
SM	NULL
,	NULL
Hansen	NULL
TH	NULL
,	NULL
Glimcher	NULL
LH	NULL
and	NULL
Korsmeyer	NULL
SJ	NULL
(	NULL
1994	NULL
)	NULL
Bel-2	NULL
is	NULL
upregulated	NULL
at	NULL
the	NULL
CD4*CD8~	NULL
stage	NULL
during	NULL
positive	NULL
selection	NULL
and	NULL
promotes	NULL
thymocyte	NULL
differentiation	NULL
at	NULL
several	NULL
control	NULL
points	NULL
.	NULL

Immunity	NULL
1	NULL
:	NULL
197-205	NULL
Kong	NULL
YY	NULL
,	NULL
Fischer	NULL
KD	NULL
,	NULL
Bachmann	NULL
MF	NULL
,	NULL
Mariathasan	NULL
S	NULL
,	NULL
Kozieradzki	NULL
I	NULL
,	NULL
Nghiem	NULL
MP	NULL
,	NULL
Bouchard	NULL
D	NULL
,	NULL
Bernstein	NULL
A	NULL
,	NULL
Ohashi	NULL
PS	NULL
and	NULL
Penninger	NULL
JM	NULL
(	NULL
1998	NULL
)	NULL
Vav	NULL
regulates	NULL
peptide-specific	NULL
apoptosis	NULL
in	NULL
thymocytes	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

188	NULL
:	NULL
2099-2111	NULL
Zhou	NULL
T	NULL
,	NULL
Song	NULL
L	NULL
,	NULL
Yang	NULL
P	NULL
,	NULL
Wang	NULL
Z	NULL
,	NULL
Lui	NULL
D	NULL
and	NULL
Jope	NULL
RS	NULL
(	NULL
1999	NULL
)	NULL
BisindolyImaleimide	NULL
VIII	NULL
facilitates	NULL
Fas-mediated	NULL
apoptosis	NULL
and	NULL
inhibits	NULL
T	NULL
cell-mediated	NULL
autoimmune	NULL
diseases	NULL
.	NULL

Nat	NULL
.	NULL

Med	NULL
.	NULL

5	NULL
:	NULL
42-48	NULL
Schonrich	NULL
G	NULL
,	NULL
Kalinke	NULL
U	NULL
,	NULL
Momburg	NULL
F	NULL
,	NULL
Malissen	NULL
M	NULL
,	NULL
Schmitt-Verhulst	NULL
A-M	NULL
,	NULL
Malissen	NULL
B	NULL
,	NULL
Hammerling	NULL
GJ	NULL
and	NULL
Arnold	NULL
B	NULL
(	NULL
1991	NULL
)	NULL
Down-regulation	NULL
of	NULL
T	NULL
cell	NULL
receptors	NULL
on	NULL
self-reactive	NULL
T	NULL
cells	NULL
as	NULL
a	NULL
novel	NULL
mechanism	NULL
for	NULL
extrathymic	NULL
tolerance	NULL
induction	NULL
.	NULL

Cell	NULL
65	NULL
:	NULL
293-304	NULL
Rincon	NULL
M	NULL
and	NULL
Flavell	NULL
RA	NULL
(	NULL
1994	NULL
)	NULL
AP-1	NULL
transcriptional	NULL
activity	NULL
requires	NULL
both	NULL
T-cell	NULL
receptor-mediated	NULL
and	NULL
co-stimulatory	NULL
signals	NULL
in	NULL
primary	NULL
lymphocytes	NULL
.	NULL

EMBO	NULL
J	NULL
.	NULL

13	NULL
:	NULL
4370-4381	NULL
Kopp	NULL
E	NULL
and	NULL
Gosh	NULL
S	NULL
(	NULL
1994	NULL
)	NULL
Inhibition	NULL
of	NULL
NF-kappa	NULL
B	NULL
by	NULL
sodium	NULL
salicylate	NULL
and	NULL
aspirin	NULL
.	NULL

Science	NULL
265	NULL
:	NULL
956	NULL
Ho	NULL
WY	NULL
,	NULL
Cooke	NULL
MP	NULL
,	NULL
Goodnow	NULL
CC	NULL
and	NULL
Davis	NULL
MM	NULL
(	NULL
1994	NULL
)	NULL
Resting	NULL
and	NULL
Anergic	NULL
B	NULL
cells	NULL
are	NULL
defective	NULL
in	NULL
CD28-dependent	NULL
costimulation	NULL
of	NULL
naive	NULL
CD4+	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

179	NULL
:	NULL
1539-1549	NULL

